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Liquid chromatography/quadrupole time of flight mass spectrometry (LC/QTOF 
MS) utilizing electrospray ionization was employed to monitor protein expression in 
Escherichia coli and Shigella organisms.  Automated charge state deconvolution, spectral 
subtraction and spectral mirroring were used to reveal subtle differences in the LC/MS 
data.  Reproducible intact protein biomarkers were discovered based on their unique 
mass, retention time and relative intensity.  These markers were implemented to 
differentiate closely related strain types, (e.g. two distinct isolates of E. coli O157:H7) 
and to correctly identify unknown pathogens.  Notable, was the distinction of multiple 
serotypes of enterohaemorrhagic E. coli which cannot be distinguished by clinical 
 xxiv 
xxv 
manifestation alone.  Additionally, speciation of Shigella was achieved, a task for which 
no commercial real-time polymerase chain reaction (PCR) primers exist.   
This method was subsequently applied to two pathogenic Clostridium species:  C. 
difficile and C. perfringens.  Due to the increased difficulty during lysis, two new lysis 
protocols were developed, and each extracted a distinct set of proteins (by both mass and 
retention time).  Extracts from both lysis procedures were utilized to discover biomarkers 
useful for identification and characterization at the species and strain levels.  These 
biomarkers were successfully implemented to identify unknowns during a blind study 
and would enhance serological and genetic approaches by serving as new targets for 
detection.  Two sets of the C. perfringens isolates that were deemed 100% similar by the 
gold standard for strain differentiation, pulsed-field gel electrophoresis (PFGE), were 
distinguished using LC/MS, demonstrating the high specificity of this approach.   
The final part of this work demonstrated the application of ultra performance 
liquid chromatography (UPLC) to this project to improve the throughput of the method.  
Given that numerous small molecule applications of UPLC have been published, efforts 
were made to examine the potential of UPLC to enhance the separation of intact proteins.  
Beginning with typically employed conditions, column temperature and organic solvent 
were optimized followed by an HPLC vs. UPLC comparison.  When applied to a mixture 
of ten protein standards, the optimized UPLC method yielded improved chromatographic 
resolution, enhanced sensitivity, and a three-fold increase in throughput.  Application of 
this method to cell lysate analysis demonstrated no compromise in chromatographic or 
xxvi 
mass spectral data quality; a reduction in run time from 75 minutes to 25 minutes was 
achieved.  
   
 
 
 
 
 
CHAPTER 1  Overview and Objectives 
 
 Public health laboratories serve to aid in the event of exposure to harmful agents 
such as pathogenic bacteria.  Exposure to these bacteria can occur naturally (e.g., 
foodborne illness) or intentionally (e.g., terrorist attack).  Each year in the United States, 
an estimated 76 million foodborne illnesses cause over 325,000 hospitalizations and 
5,200 deaths.1 In 1997 alone, costs from foodborne illnesses in America were estimated 
at $35,000,000,000 based on medical expenses and lost productivity.2 With this much 
harm occurring due to natural foodborne outbreaks, the intentional use of these agents 
would be more severe.  The gravity of these natural occurrences and potential terrorist 
situations acts as a driving force for the development of improved techniques to enhance 
current capabilities to respond to exposure events/outbreaks, and assist with forensic and 
epidemiological investigations.   
 In the event of an infectious disease outbreak or a terrorist attack, key decisions 
by hospital staff, public health officials and investigating authorities will have to be made 
to guide medical treatment, prophylaxis and remediation.  These decisions are best made 
when they are data directed.  The method described here employs liquid 
chromatography/mass spectrometry (LC/MS) to find protein biomarkers useful for 
characterization and identification of bacteria at the species and sub-species levels (e.g. 
serotype and strain etc.).  This approach is complementary and under certain conditions, 
 1 
2 
advantageous in comparison to current methods.  Incorporating additional 
complementary techniques in conjunction with existing methods of detection and 
characterization will yield a better overall understanding of the data collected and will 
allow more confident data directed conclusions to be made.   
 Of particular interest to this study were bacterial select agents and food and 
waterborne pathogens.  Select agents are microorganisms/toxins that are considered to 
have a high potential for serious illness and social disruption in the event of exposure.  
These agents are further categorized according to a combination of factors such as ease of 
dissemination, toxicity, etc. with Category A being the most potent including agents such 
as Bacillus anthracis and Yersinia pestis.3 More simply, food and waterborne pathogens 
are pathogens which may be transmitted through contaminated food or water. 
 The goal of the LC/MS method was to detect proteins that were unique to certain 
bacterial pathogens and which could be used as biomarkers for identification and 
characterization.  As with many biomolecular diagnostic approaches, the first step in the 
analysis was cultivation of the bacterial sample.  After cultivation, a simple chemical 
lysis procedure was performed to inactivate the cells and extract proteins.   
 The proteins were then separated using reversed phase liquid chromatography.  
This type of chromatography gives hydrophobicity information in the form of retention 
time where the most retained (having larger retention times) proteins are more 
hydrophobic.  Reversed phase chromatography also employs solvents that are easily 
evaporated and are more amenable to electrospray ionization-mass spectrometry (ESI-
MS)4 than the solvents typically employed in capillary electrophoresis and other 
3 
chromatography techniques such as ion exchange chromatography which tend to be 
aqueous solutions containing non-volatile salts.  The effluent from the liquid 
chromatograph entered the directly into the ESI source of the mass spectrometer.  Due to 
its sensitivity in full-scan mode and wide mass range, quadrupole time of flight5 mass 
spectrometry was utilized for mass analysis.   
 ESI produces protein spectra that contain multiply charged ions and the 
interpretation of these spectra can be challenging even for a pure compound.  To this end, 
an automated computer-based approach6 was used to deconvolute the more than one 
hundred proteins detected per lysate.  This process yielded a single spectrum containing 
the neutral (zero charge) masses of all of the observed proteins.  Once the neutral masses 
are calculated, there are a total of three pieces of information that have been obtained:  
retention time, neutral mass and relative intensity.  
 During comparison, spectra from different bacteria were first mirrored along the 
baseline to better view the differences, and then protein masses common between the two 
bacteria being compared were removed using spectral subtraction.  Spectral subtraction 
removes common masses within a given mass tolerance (± 2 Da here) leaving only the 
remaining unique masses which serve as potential biomarkers.  Once detected, the 
biomarkers were evaluated for their reproducibility in terms of mass, retention time and 
relative intensity by repeating the entire experiment a minimum of three times on three 
different days.  Due to the dynamic nature of the proteome and the production of artifacts 
during the charge state deconvolution step, not all unique masses observed after spectral 
subtraction were reproducible.  Only proteins which were found unique on all three 
4 
repeated experiments were deemed biomarkers.  Lastly, the marker proteins were further 
challenged for their utility during the identification of unknown pathogens in a blind 
study.  This LC/MS method for biomarker discovery was  applied in Chapters 4 and 5 
and then optimized in Chapter 6. 
 In Chapter 4, the efficacy of the LC/MS method for characterization of bacterial 
pathogens was examined using Escherichia coli and Shigella species.  These organisms 
are leading causes of the food and waterborne illness shigellosis which infects millions 
worldwide on an annual basis.  Additionally, the toxin they produce, the Shiga toxin 
(Stx), is considered a category B select agent.  Both qualitative (by mass and retention 
time) and quantitative (by relative abundance) biomarkers were discovered in this study 
and found to be reproducible in five repeated experiments run on five different days.  
These markers were implemented for Shigella speciation, and because no real-time PCR 
primers are available for this task, the gene sequence encoding these marker proteins 
could be used to design novel primers.  Serotype and strain level discrimination was 
achieved allowing the distinction of three serotypes of enterohaemorrhagic E. coli and 
two different isolates of the same serotype (O157:H7), respectively.  Strain level 
discrimination as demonstrated by this approach could be utilized during forensic 
traceback or food attribution investigations to pinpoint the source of an outbreak and to 
help determine if a group of infections is random or related.  This would require 
examining clinical isolates from victims and isolates obtained from swabbing the crime 
scene or suspected food items and comparing the results to determine if a relationship 
5 
exists.  The method developed and the biomarkers discovered identified over a dozen 
unknown bacteria in approximately two hours per sample post culture. 
 In Chapter 5, this work was expanded to include other types of bacteria (e.g., 
Gram positive and endospore forming).  The Clostridium species C. difficile and C. 
perfringens were chosen because they are Gram positive, sporulate, and are of interest to 
public health and homeland security.  C. difficile is the leading cause of the nosocomial 
illness antibiotic associated diarrhea (AAD) and has been stockpiled by a terrorist 
organization with the intent of deliberate use.  C. perfringens, a well known foodborne 
pathogen, is also a cause of AAD and was stockpiled by the Iraq government’s biological 
weapons program.  Additionally, the epsilon toxin of C. perfringens is a category B select 
agent.  Because they are Gram positive, the Clostridia have greater structural rigidity and 
therefore are more resistant to lysis than Gram negative bacteria such as E. coli.7 For this 
reason, two new lysis methods were developed, with each extracting distinct proteins.  
The first protocol utilized a combination of lysozyme digestion and repeated cycles of 
freezing and thawing.  The second utilized less lysozyme during the digestion step, but 
was followed by a treatment with acetonitrile and trifluoroacetic acid after the 
freeze/thaw step. 
 After lysis, the spores were removed by filtration and the extracts were analyzed 
using the LC/MS method described above.  Reproducible biomarkers were observed that 
could distinguish both Clostridium species, something that in the case of AAD can not be 
achieved by symptoms alone.  Markers from both lysis protocols were utilized to identify 
unknown isolates and to distinguish strains of each species.  Strain level distinction of C. 
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difficile could be used to direct treatment, as highly virulent drug-resistant strains have 
been reported.  In cases where isolates whose PFGE restriction patterns were 
indistinguishable, differentiation was achieved using LC/MS.  These findings encourage 
modification of the current PFGE protocols used in this laboratory to include different or 
multiple restriction enzymes for added information and specificity. 
Finally, the work described in Chapter 6 incorporates the latest advancement in 
liquid chromatography, i.e., ultra performance liquid chromatography (UPLC)8, in an 
attempt to improve the overall method throughput.  UPLC employs small (sub-2 μm 
diameter) porous particles at very high back pressures to generate more efficient 
separations in less time.  As predicted from Van Deemter theory, the plate height 
minimum in the plot of height equivalent to a theoretical plate vs. linear velocity is lower 
for sub-2 μm particles than for larger particles sizes while the linear velocity region at 
that minimum is also much longer.9 This means the use of sub-2 μm particles (1.7 μm 
here) allows for improved resolution over a wide range of flow rates.  The runtime can 
then be significantly reduced because the flow rate can be significantly increased, at no 
expense in resolution.  However, since the column diameter remains constant, as the flow 
rate is increased, there is a concomitant increase in back pressure.  Thus, UPLC is a 
combination of sub-2 μm particles used with a column and system that can withstand 
much higher pressures (e.g. 1000 bar) than those utilized in conventional high 
performance liquid chromatography (HPLC) experiments.   
One novel aspect of this work is the application of UPLC to the separation of 
intact proteins.  Due to their slow diffusivities and greater structural complexity relative 
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to small molecules, intact proteins have been problematic to chromatograph.10 This work 
utilized ten protein standards of varying size and reversed phase retention behavior as a 
model set for method development.  In addition to particle size, column temperature and 
organic modifier were adjusted for optimal performance.  The optimal method involved a 
combination of high temperature, a solvent of high eluotropic strength and small particles 
at ultra high pressure.  This method was then applied to an E. coli cell lysate and 
demonstrated improved sensitivity, and a threefold reduction of data collection and data 
analysis time compared to that of the original HPLC method.  
The work performed and the ensuing results from these three projects will be 
discussed at greater length in Chapters 4-6.  Necessary background discussion of the 
existing methods for bacterial identification and characterization is described in Chapter 
2.  Chapter 3 provides an introduction to and the rationale behind the protocols within the 
LC/MS method which was later employed in Chapters 4 and 5, and optimized in Chapter 
6.  Finally, insights, implications and potential future work resulting from this 
dissertation are detailed in Chapter 7.  The work presented here represents advancement 
in the study of diagnostic microbiology as it relates to public health and homeland 
security, built upon a foundation in analytical chemistry and achieved through the 
application of novel, cutting edge technology.  
 
 
 
 
  
CHAPTER 2  Current Methods of Bacterial Characterization  
 
2.1. Cultural Methods 
  
 Since the initial observation of bacteria in 1683 by Antoni van Leeuwenhoek11, 
the means by which bacteria are observed and characterized has experienced tremendous 
advancement.  In the modern public health domain, three approaches dominate:  culture-
based, serological and genotypic.  The culture of bacteria is a way of purifying the 
bacteria from its matrix and increasing its concentration by growth.  The time required to 
reach the desired concentration depends on the generation time (doubling time) and 
growing conditions (temperature, atmosphere and nourishment etc.).  At optimal 
conditions, the generation time can vary widely depending on the bacterium.  Escherichia 
coli for example has a generation time of 17 minutes compared to 1980 minutes (33 
hours) for Treponema pallidum.12 Techniques that have been traditionally used to identify 
bacteria post-culture include morphologic, chemotaxonomic, and biochemical tests, most 
of which require several days to perform.  The morphology of bacteria (shape, size, stain 
response, etc.) viewed with a microscope is a useful tool for grouping bacteria.  
Chemotaxonomic methods involve analysis of the chemical content of bacterial cells.  
Biochemical approaches monitor the bacteria’s ability to ferment, metabolize, or cleave 
certain compounds.13 
 8 
9 
While it is desirable for detection methods to be sensitive enough so that culture is 
not required (in order to improve assay speed), the majority of accepted methods in 
diagnostic bacteriology culture the bacteria prior to analysis.  In addition to purification 
and concentration, there are other distinct advantages to culture such as the differentiation 
of viable and non-viable cells; and cell stress or injury resulting from food processing or 
the environment can be repaired.14   
   The culture process itself has diagnostic value.  There are two principal methods 
of culture-based diagnosis, both dependant upon the type of media used for growth – 
selective or differential.  The selective technique attempts to grow unknown samples on 
different types of media, with each type designed to enhance the growth of a particular 
kind of organism while containing inhibitors to inhibit the growth of others.  The ensuing 
results are then compared to the growth trends of known bacteria for identification.  The 
differential approach cultivates bacteria on a nonselective media but in the presence of 
several indicator dyes so that different types of bacteria will be identified based upon the 
different colors they produce.13 One very common medium, MacConkey agar, functions 
as both selective and differential.  This medium contains inhibitors for the growth of 
Gram positive bacteria, thus selecting for Gram negative; and contains lactose and a pH 
indicator dye that turns red under acidic conditions.  Since acid is produced during 
lactose fermentation, the ability of unknown bacteria to ferment lactose is discerned 
based on the color (pH) of the medium after growth.  Thus, common foodborne 
pathogens such as E. coli which do ferment lactose are readily distinguished from 
Salmonella which do not.  While culture-based techniques are useful for classifying 
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unknown bacteria and can serve to direct further testing, they are generally not specific 
enough to differentiate between species or strains of bacteria and are not considered 
confirmatory techniques. 
2.2. Serological Approaches 
 Serological/immunological assays employ antibodies that react with antigens 
produced by, or located on, the surface of bacteria.  These antigens may be 
lipopolysacharides or proteins for example.  Bacteria of the same species with different 
antigens are known as serotypes.  Bacteria are often described by their serotype as in the 
case of E. coli O157:H7 which is O (lipopolysacharide) antigen number 157 and H 
(flagellar protein) antigen number 7.  Since only certain serotypes of bacteria such as E. 
coli may be toxic, serological methods are often used to distinguish between toxic and 
non-toxic bacteria.  There are two main serological techniques used to identify bacteria:  
particle agglutination and enzyme-linked immunosorbent assays. 
 Particle agglutination assays adsorb antibodies to particles such as latex and as 
multiple particles react with antigens on the same bacterium, the bound particles clump 
together (agglutinate) to form a mass of particles that is visible to the naked eye.  The 
greater the size of the particles or beads (typically > 800 nm), the greater the ease in 
which the agglutination reaction can be observed which may take up to 24 hours.  Often 
culture is not required for this technique; but contaminates can adversely effect the 
reaction so often sample clean up is necessary.15   
   Unlike agglutination assays which are used to detect intact bacterial cells using 
their surface antigens, enzyme-linked immunosorbent assay (ELISA) approaches can also 
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be used to detect individual proteins such as toxins expressed by bacteria.  ELISA, is an 
indirect immunofluorescence assay where the bacteria adhere to a microtiter plate before 
reacting with an unlabeled primary antibody.  Next, the secondary antibody which binds 
to the primary antibody, is coupled to an enzyme which after removal of unbound 
antibody, cleaves a dye substrate added to the solution resulting in a color change in the 
dye.13  Unlike agglutination assays which are used to detect intact bacterial cells using 
their surface antigens, ELISA approaches can also be used to detect individual proteins 
such as toxins expressed by bacteria. 
 The serological approaches are sufficiently sensitive such that culture is often not 
required and analysis time is rapid (≤ 1 day).  However, as with all antibody approaches, 
cross reactivity between closely related samples can occur, and these techniques are only 
applicable for bacteria to which antibodies have been made.16  
2.3. Genetic Approaches 
 
2.3.1. Real-Time Polymerase Chain Reaction 
 
While culture and serology yield useful information, ultimately a genetic 
approach is desired for confirmation of the microorganism’s identity.  First presented by 
Siaki et al. in 198817, polymerase chain reaction (PCR), is a method used to amplify small 
amounts of DNA by making repeated copies of specific strands that can then be detected 
by gel electrophoresis or fluorescence spectroscopy.13 This technique is used to 
characterize and identify microorganisms by monitoring sequences of DNA unique to a 
particular genus or species.  Starting at the location of the primer, a replicate double 
stranded DNA (dsDNA) molecule identical to the original one is produced.  The process 
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is then repeated, but this time with double the starting material and is thereby an 
exponential process.  This feature makes PCR a very sensitive technique and led to a 
Nobel Prize in chemistry in 1993.  In theory culturing is not required, however in 
practice, the task of isolating the cells so that only bacterial DNA is used and purifying of 
the cells from inhibitors in the matrix which can interfere with the polymerase reaction is 
required.  Purification can be accomplished by using immunoaffinity beads18 but these 
require antibodies and for specificity reasons stated previously, most often cultural 
enrichment is employed.   
The cycling process can continue until a desired concentration is obtained or until 
the reactants are consumed and the reaction plateaus.  Some attempts to quantify the 
DNA produced at the end of the reaction have been made but it is difficult to correlate the 
amount of DNA during the plateau stage with the amount of starting material.  For this 
reason, Higuchi et al. used a fluorescent probe that emits signal only when bound to 
dsDNA.19 The fluorescence intensity and therefore the reaction can be monitored in ‘real-
time’ as dsDNA is continually produced.  From the number of cycles required to reach 
the plateau phase, the amount of DNA at the beginning of the reaction can be calculated.  
This quantitative PCR is commonly referred to as real-time PCR.   
Real-time PCR is categorized as a rapid technique because it can often be 
performed after culturing in 0.5 - 4 hours.  While sensitivity and speed are advantages, 
some limitations are also present.  One, this method requires that primers be available for 
use.  Bacteria with out available primers are not suitable for detection by real-time PCR.  
Two, since it is a targeted approach the information obtained from the primers may be 
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unreliable or insufficient if bacteria were genetically engineered for such purposes as 
drug or heat resistance or had undergone natural or environmental mutagenesis.  Finally, 
small genetic differences unique to one strain of bacteria such as single nucleotide 
polymorphisms (SNPs) could occur between the primer locations and be missed during 
the comparison of two closely related strains.20  
2.3.2. Pulsed-field Gel Electrophoresis 
 
 Another genomic approach that is widely used to characterize bacterial pathogens 
is pulsed-field gel electrophoresis (PFGE).  First presented in 1983, this technique 
separates DNA fragments using gel electrophoresis in a pulsed electric field and has three 
main steps.21 First, after culture of bacteria, the cells are lysed and the intact chromosome 
is removed.  Next, using a restriction endonuclease enzyme, the chromosome is digested 
into fragments (usually 10-20) of DNA that range in size from 10-1000 kb (~ 3.13 – 313 
MDa).  Finally, these fragments are electrophoretically separated according to size using 
a pulsed-field to create a pattern unique to that isolate of bacteria.22, 23   
 The electric field is pulsed in varying angles at different time intervals to better 
separate the large DNA fragments which are not efficiently resolved using traditional 
electrophoretic techniques.  Using a traditional (continuous) field, these large 
chromosomal fragments will elute together as a single band.  But upon varying (pulsing) 
the field at different angles and at different time intervals, the enough change in the 
mobility the fragments occur to effect separation.  Computer images of the gel patterns, 
also known as restriction patterns, are then compared to historical samples or samples 
from other laboratories etc.  Highly similar or identical patterns indicate two isolates are 
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related and differences in the restriction patterns signify differences in nucleotide 
sequence.22 
 PFGE is considered a non-targeted screening approach and is therefore able to 
detect subtle differences missed by targeted approaches such as serology and real-time 
PCR.  The specificity achieved by PFGE has made it the ‘gold standard’ technique for 
strain typing and it is widely used for epidemiological purposes.  Outbreaks are detected 
and monitored through a program known as PulseNet which compares and certifies 
PFGE patterns from public health laboratories around the country.24   
 The advantages of PFGE are that primers or antibodies are not required for 
analysis and that strain-level typing is straightforward.  However, because optimal 
digestion for different types of bacteria require different restriction enzymes, prior 
knowledge of the genus of the sample is required.  Another limitation common to all 
genotypic approaches is that the mere presence of a gene doesn’t necessarily correlate to 
protein expression.  This consideration is of particular importance for bacterial pathogens 
which are known to contain genes that are not expressed25-27 which could result in a false 
positive indication of pathogenicity.  Furthermore, PFGE is not a rapid technique since it 
requires a minimum of two days to perform after culturing.  
2.4. Mass Spectrometric Approaches 
2.4.1. Small Molecule Analysis 
 Mass spectrometry was first applied as a tool for the identification and 
characterization of microorganisms in the 1970’s.28 Early approaches typically involved 
gas chromatography/mass spectrometry (GC/MS) both for the information provided by 
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chromatography as well as the added specificity and sensitivity afforded by MS 
compared to a flame ionization detector (FID).  Furthermore, using tandem mass 
spectrometry (MS/MS) or selected ion monitoring (SIM) the background noise was 
greatly reduced because only ions of interest were monitored increasing sensitivity.  
Additionally, a GC/MS technique employing high temperature pyrolysis of intact bacteria 
to introduce volatile compounds into the gas phase has also been utilized.28 The early 
mass spectrometric approaches typically were chemotaxonomic in nature and monitored 
small volatile molecules such as lipids and metabolites.20 For compounds that were less 
volatile or were too polar, such as carbohydrates, derivatization reactions could be 
employed to make them more amenable for GC analysis.  Some specific techniques 
utilized for speciation include monitoring the fatty acid content from phospholipid 
backbones and detecting carbohydrate profiles.20 These fatty acid or sugar profiles were 
then compared with other bacteria either manually or with the use of spectral libraries.28 
Additionally muramic acid, one of the constituents of bacterial peptidoglycan, which is 
not synthesized by mammalian enzymes, can be monitored by GC/MS to detect the 
presence of bacteria in environmental or clinical samples and can also distinguish 
bacterial from viral infections.20 To avoid the time consuming step of derivatization and 
to monitor phospholipids directly, fast atom bombardment (FAB) mass spectrometry was 
used in the early 1990’s due to its ability to analyze polar compounds.29 More recent 
techniques such as desorption electrospray ionization (DESI) have been used to discover 
sub-species distinctions in Salmonella typhimurium and E. coli by monitoring lipid 
profiles.30 
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 The analysis of small molecules such as lipids and carbohydrates can be 
problematic because many of those compounds are not unique to a particular strain of 
bacteria (unlike certain DNA or protein sequences) therefore limiting their overall 
discriminatory power as biomarkers.  Examples include fatty acids, some which are 
shared over a wide range of bacteria, phospholipids which occur throughout nature 
therefore possibly leading to background contamination or false positives, and hydroxy 
fatty acids which are found in normal blood and tissues and could interfere during clinical 
analysis.20 Furthermore, techniques that deal more directly with the function of the 
organism such as genomic or proteomic information are more likely to gain acceptance in 
the microbiology community. 
2.4.2. Large Molecule Analysis 
 The advent of matrix assisted laser desorption ionization (MALDI) and 
electrospray ionization (ESI) allowed soft ionization of highly polar compounds and both 
have become the preeminent ionization techniques for the analysis of large biomolecules 
e.g., DNA, by mass spectrometry.20 One example of the use of mass spectrometry to 
classify bacteria by their DNA, is polymerase chain reaction – mass spectrometry (PCR-
MS).20 As described earlier, when PCR amplifies DNA, the products (amplicons) are 
monitored by fluorescence spectroscopy (FS).  However, the low level of specificity 
obtained by FS makes it difficult to detect small differences in the nucleic acid sequence 
such as a single A to T or G to C switch (SNPs) which yields mass differences of 9 and 
40 Da, respectively.  Mass spectrometry offers enhanced specificity thereby minimizing 
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false positives.  This technique has been used to distinguish two species of Bacillus using 
the same PCR primers.31  
 MALDI and ESI have furthered the mass spectrometric analysis of proteins as 
well.  Interestingly, key differences between closely related strains may occur at the 
proteome level that do not occur at the genome level.  In fact, the data collected from 
proteomic approaches is much more than just an indirect genetic analysis.  This is 
because the proteome is one to two orders of magnitude larger than what the genome 
encodes.32 If an organism’s genome contains 20,000 genes, the number of unique 
proteins in that organism may be as many as 200,000 to 2 million – information lost by 
detecting DNA only.  This large difference between the size of a genome and its 
respective proteome is due to the various isoforms of proteins which are largely a result 
of posttranslational modification (PTM).  As their name implies, PTMs occur after the 
genetic contribution to protein structure is complete.  Examples of PTMs include the 
adding of carbohydrates (glycosylation) or lipids (prenylation).  One of the dominant 
PTMs in bacteria is removal of the N-terminal methionine and is estimated to occur in 
50% of bacterial proteins.33 In total, the differences that can be observed during the 
comparison of bacterial proteins can be qualitative:  the presence/absence of proteins, 
protein sequence mutations and PTMs, or quantitative, i.e., varying levels of protein 
expression.34 
 Often proteomic analysis by MS is coupled with a separation technique such as 
liquid chromatography (LC) and two LC/MS workflows are commonly employed.  The 
first, known as the bottom-up approach, uses a protease such as trypsin to digest all of the 
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proteins in the cell lysate.35 The resulting peptides are then analyzed by two dimensional 
(2D) LC and MS and subsequent database searches are used to match the peptide masses 
to known peptide sequences.  The second approach is top-down, and first isolates intact 
proteins of interest either by LC/MS or 2D gel electrophoresis so that only the proteins of 
interest are sequenced.36 The last step of sequencing is performed either inside the mass 
spectrometer or by analyzing peptides after proteolytic digestion.35, 36 
 The bottom-up approach is more time consuming because of the digestion (about 
2 hours), the 2D LC separation and the added data analysis time due to the large number 
of peptides produced.  The method described here is a top-down approach where LC/MS 
was used to identify the unique proteins rather than 2D gel electrophoresis.  LC/MS is 
automated and has improved dynamic range, resolution and reproducibility and is less 
time consuming than gel electrophoresis.37 Moreover, the combination of mass and 
retention time information means LC/MS could be considered a 2D approach.  The top-
down approach has the advantage of detecting the mass of the intact protein prior to 
sequencing.  Knowing the intact mass allows immediate detection of modified proteins 
during comparative proteomic investigations. 
 The additional step of sequencing and database searching was not 
employed in the method described here.  The reason being unique and reproducible 
biomarkers and protein profiles were observed allowing for identification at the species 
and strain levels without knowing the actual identity of the proteins involved.  Therefore, 
this approach could potentially be applied to bacteria whose genomes have not been 
sequenced.  In contrast, proteomic approaches that rely upon database results for 
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identification purposes are of little to no use for such bacteria.  Finally, not sequencing 
the proteins avoids a timely digestion step which resulted in a reduced analysis time. 
  
CHAPTER 3  Overview of Analytical Procedures 
 
3.1. Cultivation of Bacterial Cells 
  
 The bacterial pathogens that were investigated are:  E. coli, Shigella species and 
Clostridium species.  Shiga toxin producing E. coli and Shigella are foodborne 
pathogens, and the toxin they produce is a Category B select agent.  These two pathogens 
cause the enteric disease Shigellosis.  Ubiquitous in the environment, Clostridium species 
are toxin producers and cause illnesses such as gangrene and pseudomembranous colitis, 
and are a common cause of nosocomial infection.38 In addition to the characteristics used 
to identify these microorganisms as select agents and or foodborne pathogens; other traits 
commonly used for their characterization are listed in Table 1. 
 
Table 1.  Characteristics used to describe the bacteria of interest to this study. 
 
Bacteria Gram +/- Aerobic Shape Sporogenic Motile 
Shigella 
spp. 
 
- Yes Bacillus No No 
E. coli 
 - Yes Bacillus No Yes 
Clostridium 
spp. 
 
+ No Bacillus Yes Yes 
 
 
 The bacteria were obtained from clinical isolates stored at the Virginia Division of 
Consolidated Laboratory Services (DCLS) or were purchased from American Type 
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Culture Collection (ATCC, Manassas, VA).  Since no official nomenclature for 
describing strains exists, in-house accession numbers were used to describe the clinical 
isolates as different strains and the commercial strains were distinguished by their ATCC 
product number Table 2.   
 
Table 2.  The isolates used in this study.  NM = non-motile, NA = not applicable,   ND = not 
determined.  
 
Family Genus Species Serotype Strain 
Enterobacteriaceae Escherichia coli O157:H7 06-1464 
Enterobacteriaceae Escherichia coli O157:H7 06-1439 
Enterobacteriaceae Escherichia coli ND 06-0004 
Enterobacteriaceae Escherichia coli ND 06-0006 
Enterobacteriaceae Escherichia coli O111:NM 06-1440 
Enterobacteriaceae Escherichia coli O26:H11 06-1418 
Enterobacteriaceae Shigella sonnei NA 06-1364 
Enterobacteriaceae Shigella sonnei NA 06-1362 
Enterobacteriaceae Shigella flexneri ND 04-0497 
Enterobacteriaceae Shigella flexneri ND 06-0967 
Clostridiaceae Clostridium perfringens ND 06-0385 
Clostridiaceae Clostridium perfringens ND 06-0387 
Clostridiaceae Clostridium perfringens ND 05-0025 
Clostridiaceae Clostridium perfringens ND 05-0070 
Clostridiaceae Clostridium perfringens ND 05-0076 
Clostridiaceae Clostridium perfringens ND 04-1464 
Clostridiaceae Clostridium perfringens ND 04-1672 
Clostridiaceae Clostridium perfringens ND 04-1665 
Clostridiaceae Clostridium difficile A 43594 
Clostridiaceae Clostridium difficile B 43593 
Clostridiaceae Clostridium difficile C 43596 
Clostridiaceae Clostridium difficile F 43598 
Clostridiaceae Clostridium difficile ND 700792 
 
  
 All bacteria were grown on trypticase soy agar plates containing 5% sheep’s 
blood.  The tryptone, soytone and sheep’s blood cells provide a source of nutrients 
(sugar, nitrogen, minerals) to enhance cellular growth.  Depending on the bacteria, either 
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anaerobic or aerobic conditions were employed (Table 1).  A temperature of 37oC was 
maintained for all bacteria.  Efforts were made to ensure that the growing conditions and 
concentration of cells analyzed were kept constant.  The Shigella, Escherichia and 
Clostridium perfringens cells were grown for 24 hours, however the more fastidious 
Clostridium difficile required 48 hours.  To circumvent this, twice the number of plates 
was used to cultivate C. difficle and after 24 hours, the cells from two plates were 
combined and added to form one cell suspension. 
 After the 24 hour growth period, the cells were removed from the plate using a 
sterile disposable swab and placed in a test tube containing 1 mL of sterile water until the 
optical density reading reached 1.0 using a MicroScan Turbidity Meter (Dade Behring 
West Sacramento, CA).  The water used had been autoclaved and purified using the RiOs 
5 Water Purification System (Milipore Billerica, MA).  A 500 μL aliquot of the cell 
suspension was added to a 1.5 mL protein LoBind micro-centrifuge tube (Eppendorf, 
Westbury, NY) and washed three times with 500 μL of sterile water followed by 
centrifugation (6000 × g at room temperature for 5 minutes) to remove residual media.   
3.2. Cell Lysis 
3.2.1. Gram Negative Bacteria 
 Bacteria are classified in various ways, one of them as being Gram positive or 
Gram negative.  This difference is based on the amount of peptidoglycan (linear 
polysaccharide chains cross-linked by tetrapeptides) in the cell structure.  Gram negative 
cells have three layers.  First, an outer membrane consisting of protein, 
lipopolysaccharide and phospholipids, next, a peptidoglycan layer, followed by the 
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cytoplasmic membrane.  The cell envelope of Gram negative bacteria contains 10-20% 
peptidoglycan compared to 50-80% in Gram positive.7 The name Gram positive/negative 
arises from the results of a test known as the Gram stain.  This test employs a dye that 
turns red upon reacting with peptidoglycan.  Since Gram negative cells have significantly 
less peptidoglycan, they produce a faint pink color and are assigned a negative result, 
while the Gram positive cells produce a deep red color indicating a positive result.    
 Initial work in this study involved Gram negative cells.  After the final wash step 
described above, the cells were resuspended in 150 μL of the lysis solution (1:1 H2O: 
acetonitrile, 0.1% v/v trifluoroacetic acid (TFA)).  Unlike detergents, which are 
sometimes used for the chemical lysis of cells, the lysis solution (1:1 H2O:acetonitrile, 
0.1% v/v TFA) is amenable to both MALDI and ESI analysis.  After the lysis solution is 
added, the samples are vortexed for a few seconds and lysis is complete.  The suspected 
mechanism of lysis involves the solubilization of cell wall lipids which may result in 
swelling and bursting of the cells as well as denaturation of the cell wall and other 
proteins.  That the lysis solution denatures proteins is advantageous in that it will likely 
inactivate protein toxins such as the Shiga toxin in addition to inactivating proteases 
which will degrade other proteins of interest.  It is expected that many of the proteins 
extracted using this procedure are highly soluble cytosolic proteins.37 Many of the less 
soluble proteins from the outer membrane and other cellular material precipitate 
immediately after vortexing the samples.  In order to prevent some of the cellular debris 
from clogging the LC column, the samples are centrifuged at 4100 × g for 4 minutes at 
room temperature prior to analysis, making a pellet of the debris and clarifying the 
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supernatant.  Following centrifugation, 65 μL of supernatant was removed and placed in 
an autosampler vial containing a microvial insert for analysis.   
3.2.2. Gram Positive Bacteria 
 Gram positive bacteria lack the outer membrane layer found in Gram negative 
cells but have a significantly larger peptidoglycan layer.  Since it is this layer that 
provides the most structural strength and rigidity to the cell, Gram positive cells are much 
more resistant to disruption and lysis.  Applying the Gram negative lysis method to the 
Gram positive Clostridia resulted in very few proteins being extracted.  New methods 
were attempted, and two protocols were successful with each extracting a distinct (by 
both mass and retention time) set of proteins.  After washing the cells as described above, 
the first method involved adding 150 μL of 1 mg/mL lysozyme (HEWL) (Sigma-Aldrich 
St. Louis, MO) in 20 mM NH4OAc and incubating at 37oC for 30 minutes.  Lysozyme 
disrupts peptidoglycan structure by hydrolyzing β-1,4 linkages of the polysaccharide 
chains.  This was followed by four cycles of freeze/thaw in liquid nitrogen and a 37oC 
water bath respectively.  The second lysis method began with 75 μL of 1 mg/mL 
lysozyme in 20 mM NH4OAc and incubating at 37oC for 30 minutes, followed by four 
cycles of freeze/thaw.  Then, 75 μL of 1:1 H2O: acetonitrile, 5% v/v TFA was added.  
The combination of these steps was required to recover a similar amount of proteins as 
seen in the Gram negative protocol.  Each individual step of lysis protocols resulted in 
insufficient lysis, requiring a combination of disruption techniques.  
 In addition to Gram positive bacteria being more difficult to lyse, some Gram 
positive bacteria (from the phylum Firmicutes) are known to sporulate posing greater 
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difficulty in lysis and inactivation.  Endospores are resistant to extremes of pH, 
temperature, certain disinfectants and radiation.  For this reason, endospores are regarded 
as the most resistant of any known biological structure.39 Indeed, viability studies using 
the lysis procedures described above revealed that neither lysis method was capable of 
inactivating the endospores.  Given that under idealized conditions (such as laboratory 
cell culture) endospore forming bacteria may produce only a small amount of spores, it 
was more straightforward to remove the endospores rather than attempting to lyse them.  
To this end, after centrifugation at 4100 x g for 4 minutes at room temperature to pellet 
the debris and clarify the supernatant, the supernatant was filtered using a disposable 
syringe and blunt tip needle (BD, Franklin Lakes, NJ), and a 0.22 μm, 4 mm 
polyvinylidene fluoride (PVDF) low protein binding GV filter (Milipore, Billerica, MA).  
Subsequently, 65 μL of the filtered supernatant was transferred to an autosampler vial for 
analysis. 
3.3.  Liquid Chromatography 
3.3.1. High Performance Liquid Chromatography 
 
Prior to detection by mass spectrometry, the proteins from the lysate are separated 
using high performance liquid chromatography (HPLC).  The purpose of this prior 
separation is to simplify the detection process by reducing the number of proteins that 
enter the mass spectrometer at any given time.  Reversed phase chromatography was 
chosen because of its use of volatile, water-miscible solvents.  These solvents allow for 
easy removal which is advantageous for down stream applications such as fraction 
collection and detection by mass spectrometry.  Gradient elution is most often used to 
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separate protein mixtures and employs two mobile phases.  The amount of organic 
solvent (% B) is increased until a sufficient amount is present to displace the protein from 
the site of adsorption causing elution from the column.  Since the % B is increased slowly 
over time and proteins with the larger amount of or more easily accessible hydrophobic 
regions will stay adsorbed to the column longer, hydrophobicity is generally proportional 
to retention time.40 However, other factors such as charge and conformation of the 
protein can play a small role in the separation as well.  
The liquid chromatograph used was an Acquity (Waters, Milford, MA).  The 
gradient conditions are listed in Table 3, where A = 1% formic acid in deionized water 
and B = 1% formic acid in 2-propanol.  The water was purified in house to yield organic-
free 18.3 MΩ × cm using an E-pure purification system (Barnstead International 
Dubuque, IA). The HPLC grade solvents 99% formic acid and 2-propanol were 
purchased from Fisher Scientific (Fairlawn, NJ) and Honeywell Burdick and Jackson 
(Morristown, NJ), respectively.  The column used was a nonporous polymeric column 
made from polystyrene-divinylbenzene (PSDVB), Prosphere P-HR 2.1 x 150 mm, 4 μm 
particle size (Alltech, Columbia, MD) and was operated at a temperature of 50oC.  To 
help preserve the samples, the autosampler was maintained at a temperature of 15oC prior 
to administering the injection volume of 20 μL.  A typical chromatogram of an E. coli 
O157:H7 isolate is shown in Figure 1. 
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Table 3.  LC gradient conditions used in this study.  All steps in the gradient were linear. 
 
Time (min) A% B% 
  0.00 95 5 
60.00 45 55 
65.00 5 95 
70.00 5 95 
70.01 95 5 
75.50 95 5 
 
Time
10.00 20.00 30.00 40.00 50.00 60.00 70.00
%
0
100 30.52
26.83
25.33
1.83
3.11 20.04
8.23
18.16
21.84
64.83
62.96
32.56 34.45 38.23
58.1144.05
70.73
70.50
 
Figure 1.  A typical HPLC/MS chromatogram from an E. coli cell lysate.  Shown is E. coli O157:H7, 
accession # 06-1439.  The y-axis represents % relative intensity and the x-axis is time in minutes. 
 
 
 The gradient conditions in Table 3 are a compromise between improved 
resolution and maintaining good peak shape.  The slope of the gradient is one of the 
simplest ways to control the peak shape of proteins with the larger the % B/min yielding 
the sharpest peaks.  However, it is the difference in % B at the point of elution that 
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distinguishes the proteins so increasing the rate of change of organic content results in a 
decrease in resolution.  The majority of proteins elute prior to 55% B with only a few 
eluting during the ramp to 95% B.  The hold at 95% B is to help clean the column of 
lipids and contaminates in the mobile phase such as polyethylene glycol, and is followed 
by a hold at 5% B to allow the column to equilibrate to initial conditions prior to the next 
injection. 
3.3.2. Ultra Performance Liquid Chromatography 
 Ultra performance liquid chromatography (UPLC) involves the separation of 
compounds using sub-2 μm particle sizes at pressures that exceed the capacity of 
standard high performance liquid chromatographs.  Van Deemter curves (plate height vs. 
linear velocity) for applications utilizing sub-2 μm particles predict lower plate heights 
(H) over a wider range of linear velocity than with larger particle sizes.8 The lower H 
values occur because H is proportional to the particle diameter (dp).  The optimum linear 
velocity is higher and occurs over a wider range due to the reduced resistance to mass 
transfer (C term in the Van Deemter equation); a consequence of using particles with a 
smaller diameter.9 Lower plate heights result in better resolution (see Equations 1 and 2) 
and the wide range of linear velocities at this plate height means the flow rate can be 
increased while maintaining equal chromatographic resolution (Rs), yielding shorter 
runtimes.  Increased column back pressure has also been shown to improve protein 
recovery from the column.41 To better ascertain the benefit received from UPLC vs. 
HPLC, nearly identical columns were utilized.  The HPLC column was the narrowbore 
X-bridge C18 BEH 300 Å 2.1 × 150 mm, 3.5 μm (Waters, Milford, MA).  According to 
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the manufacturer, the UPLC column was identical (e.g., ligand density, pore size, carbon
load) to the HPLC column except in particle size (1.7 μm). 
 
Chromatographic resolution (Rs) is described by the following equation: 
 
Rs = ⎟⎠
⎞⎛⎞⎛ −1 kN α ⎜⎝ +⎟⎠⎜⎝ 14 kα         (1) 
 = selectivity, and k = retention factor 
(capacity factor). 
The separation efficiency (N) equals: 
N = 
Where, N = separation efficiency (plate number), α
 
      
H
L  = 
phd
Where, L = column length, H = plate height, h = reduced plate height, and dp = particle 
  
Therefore, since N is proportional to
L                   (2) 
 
diameter. 
N , Rs is inversely proportional to dp:   
                                                         
                                                     Rs ∝N ∝  
pd
1             
 
 While chromatographic separation helps to simplify the sample prior to detection 
and yields information on individual protein reversed phase retention behavior, 
chromatography alone is rarely enough to distinguish two closely related strains of 
bacteria.  Occasionally a unique peak can be observed in the chromatogram, but often 
differences in the proteins are very minute such as a PTM or a single amino acid 
substitution, either of which will likely not have a significant impact on the retention of 
the protein.  Furthermore, even with optimized conditions, in mixtures as complex as 
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bacterial cell lysates, co-elution of proteins will occur.  A sensitive, and specific detection
system such as mass spectrometry is needed that can further
 
 resolve co-eluted proteins.   
.4. Mass Spectrometry 
ters, Milford, 
MA).  The Q-TOF has two quadrupoles (Q) prior to the orthogonal acceleration time of 
flight (TOF).  Table 4 lists the source conditions for the mass spectrometer.  These and 
L/min; and optimal sensitivity and resolution for bovine serum albumin.  Positive ion 
ESI was used to create ions that were monitored over a mass range of 620-2450 Da and 
resolved in single reflectron (V) mode. 
Capillary + 3.9 kV 
3
The mass spectrometer for this project was a Q-TOF Premier (Wa
the other parameters used in the MS method were optimized for best desolvation at 0.225 
m
 
Table 4.  Source conditions of the mass spectrometer. 
 
Cone voltage 40 V 
Source Temperature 115oC 
Desolvation Temperature 500oC 
Desolvation Gas Flow 900 L/hr 
 
 
ESI is an atmospheric pressure technique where liquid is passed through a 
charged capillary causing the liquid to form an aerosol spray of fine charged droplets.  As 
the droplet sizes are reduced, the analyte molecules inside the droplets are removed and 
thereby enter the gas phase.42 In full-scan mode (the mode used here), the two quads are 
in radio frequency (RF) only mode and act as ion guides rather than mass analyzers.  
Once the ions enter the quads, they have a trajectory that is hyperbolic in motion that is 
governed by the Mathieu equation.  Mass analysis in a TOF is based on the mass 
31 
dependence of ion velocity43 and, that for a given velocity over a fixed distance, the time 
taken to travel that distance is easily obtained.  The set of equations44 that govern this 
process is as follows:  
The kinetic energy of an ion accelerating in an electric field (E) is given by: 
2
2mv  =  zeE                                          (3) 
Where, m = mass, v = finally velocity achieved during acceleration, z = number of 
charges, e = charge of an electron. 
 
It then follows that: 
 
m
zeE2v  =                                           (4) 
 
 
t tube, then the time, t, taken to travel 
is distance is given by: 
 
If d, is the distance that an ion travels in the fligh
th
 =  d
eE
zm
2
)/(   
m
zeE
d
2
t  =  d/v  =        
 
Since d s fixed, e is a universal constant, and E is held constant in the mass spectrometer, 
t is then
 
(5) 
 i
 directly proportional to the square root of (m/z) times a constant, C. 
t  =  C )/( zm                                      (6) 
 
Since t is proportional to (m/z), ions of a larger (m/z) take longer to travel to the detector 
and vise versa. 
 
When comparing results from different days, it is crucial that the instrument is 
providing optimal and reproducible results.  For this reason, prior to each analysis, the 
instrument is calibrated and the mass resolution at full width half maximum (RFWHM) is 
recorded as a quality control measure.  The calibrant used was NaI because it produces a 
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wide range of ions allowing the instrument to be calibrated from 300 – 2500 Da.  The 
daily specifications required of the instrument are:  a mass error of no more than 
approximately 5 ppm and a RFWHM ≈ 10,000.  The mass accuracy is calculated as follows: 
           
A
IA MM − 6
M
 x 10   =  mass error (ppm)            (7) 
 
n in equation 8: 
 
Where MA and MI are the actual mass and indicated mass respectively, in units of Da.
 
he resolution is calculated as show
 
T
I
I
M
M
Δ  =  RFWHM                             (8) 
 
here ΔMI = the full peak width at half maximum height (in Da) of the ion of interest.   
 
3.5.1. Manual Interpretation  
A critical aspect of this project was the data analysis and there are two key issues 
per the data 
analysis step by decreas required to report 
act that as proteins undergo the electrospray process, multiply charged 
ions are
 
W
 
The Na8I7+ cluster ion at 1072.249483 Da was utilized for both calculations. 
 
 
3.5. Data Analysis 
 
pertaining to it:  data complexity and the amount of data collected.  Both ham
ing the throughput and increasing the time 
results to medical staff/investigating authorities.  The complexity of the data largely 
arises from the f
 produced (Figure 2).  While this aspect has been a major advantage of ESI by 
allowing large biomolecules to be observed on inexpensive mass analyzers of moderate
mass range (< 3000 Da) such as quadrupoles, the envelope of multiply charged ions can 
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be challenging to interpret even for a pure compound.  Furthermore, a mixture of prote
of different mass may have overlapping charge states in their envelopes and whic
states belong to which protein may be unclear, making the spectral interpretation of a 
ins 
h charge 
protein mixture significantly m re difficult.  Even with the use of chromatography, this 
scenario occurs often, for with complex mixtures like cell lysates, co-elution of proteins 
ill be common. 
 
spray 
icates 
mass/charge ratio (m/z).   
ss 
m/z
o
w
 
 
Figure 2.  A mass spectrum depicting the envelope of multiply charged ions produced by electro
ionization of a protein.  The y-axis represents percent relative intensity and the x-axis ind
  
 The most common method of addressing the complexity of interpreting ESI ma
spectra of proteins is to employ computer-based algorithms.  To evaluate their efficacy 
for charge state deconvolution, one can initially test the method on standards of known 
1200 1300 1400 1500 1600 1700 1800 1900 2000 2100
%
0
100 1590.20
1431.27
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1788.87
1596.18
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1306.15
1436.67
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1607.29
1795.481441.66
1801.48
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1446.69
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mass.  However for quality assurance purposes, some manual interpretation skills are 
beneficial when proteins of unknown mass are being analyzed, as in a cell lysate analysis.  
Some guidelines that can assist with the manual interpretation of protein mass spectra 
acquired using ESI are given below.  The mass/charge ratio (m/z) is obtained from mass 
spectral analysis and the mass spectrum is a plot of intensity vs. m/z (Figure 2).  
However, there are three unknowns in the mass spectrum:  the number of charges (z), the 
eutral (zero charge) mass (M), and the mass of the adduct ion (ma).  The charges 
received by a protein in positive ion mode are most often solvent adducts bonded by 
ion/dipole force.  The mobile phase used in this study is acidic (1% v/v formic acid, pH ≈ 
2.5).  For this reason, the most common adduct is a proton (H+) weighing 1 Da.  The 
number of charges attributed to each peak (n) is discrete (where n is used for the number 
of charges to avoid confusion with z), having only integer values with each peak in the 
envelope being one charge away from its neighboring peak.  The charge state can be 
determined by using two adjacent peaks and solving a simultaneous equation beginning 
with:   
                                               m/z  = 
n
n
nmM a )( +                 (9) 
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 Given the mass spectrum in Figure 2, and letting ma be equal to H+ (1 Da), the  
two adjacent m/z peaks at 1590.20 and 1431.27 (the latter having one more charge than 
the former) can be used to determine the charge state as follows:   
 
1590.20 = 
n
                              1431.27 = nHM )(
++
)1( +n  
 
Letting H+ = 1, solve for M: 
 
1590.20n = M + n                                        1431.27(n + 1) = M + (n + 1) 
 
              1589.20n = M                                              1430.27(n + 1) = M  
 
Since M = M,  
 
1589.20n = 1430.27(n + 1)  
 
Solve for n: 
        
1589.20n = 1430.27n + 1430.27 
 
158.93n = 1430.27 
 
n = 9 
))1(( ++ +HnM
 
Recall that: 
 
1590.20 = 
n
nH )++                                M(
 
Since H+ = 1, and n = 9, it then follows that:  
 
1590.20 = 
9
)9( +M                                
 
Now solve for M: 
 
14311.80 = M + 9  
 
M = 14302.80 
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 Since there is a certain amount of error with each peak measurement, after the 
charge state for two of the peaks has been determined, the charge states can then be 
assigned to all peaks in the envelope.  Once each peak has been assigned a charge state, 
ach one can be used to determine M and then determine the mean M value.  The 
unweighted average of the M values in Table 5 is 14302.89 Da. 
 
Table 5.  The M values determined f multiply charged ions in Figure 
2. 
e
 from each peak in the envelope o
m/z n M 
1192.96 12 14303.52 
1301.23 11 14302.53 
1431.27 10 14302.70 
1590.20 9 14302.80 
1788.87 8 14302.96 
2044.35 7 14303.45 
 
 
 A simpler way to det cular peak is to examine 
the mass difference between the 12C 13  singly charged species will have 
an isotopic difference of 1 Da, 0.5 for dou
As mentioned previously, once a charg rmined, the neighboring peaks will 
differ by one charge, allowing all peaks to be
species, when the charge state (n) of a peak is known, the neutral m e 
determined by: 
M =
  
 The problem with this method is that etermining the isotopic difference is 
dependant on the resolution of the mass spec ore, the utility of this 
ermine the charge state for a parti
 and C isotopes.  A
bly charged, 0.33 for triply charged, and so on.  
e state is dete
 assigned a charge state.  For a protonated 
ass (M) can b
 n[(m/z) – 1]          (10) 
d
trometer.  Theref
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m  will decrease with decreasing MS resolution:  ion cyclotron resonance > Orbitr
> TOF > quadrupole.  For the instrument used in this study, having a RFWHM ≈ 10,00
m/z 1000, the highest charge state that can be accurately be determined at m/z 1000 on a 
centroided spectrum is +10 (Δ = 0.1).  Figure 3 depicts a centroided version of the
charge state of the protein shown in Figure 2.  This means that th
ethod ap 
0 at 
 +10 
e above method of 
harge state determination is only applicable to proteins weighing approximately 10,000 
 or less.   
 
 
Figure 3.  Close inspection of the 1431.27 ion in Figure 2 allows charge state determination.  The 
moothed (bottom) then centered (top).  The isotopic separation of 0.1 Da indicates a 
+10 charge state for this ion.  The M value from this peak corresponds to 14302.70 Da. 
m/z
c
Da
spectrum is first s
 
  
1430.900 1431.000 1431.100 1431.200 1431.300 1431.400 1431.500 1431.600 1431.700
%
0
100
%
0
100 1431.27
1431.18
31.08
1430.99
1431.37
1431.47
1431.514 7
1431.67
1431.27
1431.17
1431.08
1431.47
1431.58
1431.37
38 
 The arduous task of manually determining the neutral masses of hundreds of 
proteins per isolate during cell lysate analysis and the limited ability of most commercial 
instruments to allow visual charge state determination make clear the need for using 
computer based approaches. 
3.5.2. Chemometric Methods 
Not long after the first protein was analyzed by ESI-MS, computer based 
chemometric methods were used to deconvolute multiply charged protein ions into their 
eutral masses (Figure 4).  The first method was developed by Mann et al. 45 This 
algorithm satisfied the two main goals of identifying the charge state of each ion in the 
envelope and determining the neutral mass of the parent ion, but had the disadvantages 
that in the deconvoluted spectrum, there were artifact peaks other than the protein of 
interest and the baseline increased with mass range.  Other algorithms were soon 
developed46, 47 notably one developed by Hagen and Monnig which corrected the rising 
of the baseline with mass and filtered out more noise giving cleaner deconvoluted 
spectra, but all quantitative information was lost.48 Today, the most commonly used 
method is known as Maximum Entropy (MaxEnt 1) developed by Ferrige et al.49, 50 This 
method produces few artifacts, is quantitative and can effectively resolve mixtures of 
proteins (Figure 4).  While this algorithm has been in use for years, it can only process a 
single or few chromatographic peaks at a time.  For this reason a recently developed 
software automatically deconvolutes entire chromatograms by dividing the data into time 
intervals, performing sequential deconvolutions, and then summing the centered data 
n
software known as Protrawler6 (Bioanalyte, Portland, ME) can be employed.  This 
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together into one text file containing neutral masses, intensities and retention times.6 A
seen in Figure 4, the calculated mass for the protein in Figure 2 is 14303.83 Da, which is 
very similar to the unweighted average that was obtained by manual calculation, 
14302.89 Da.  The results fro
s 
m MaxEnt1 are slightly high (+ 0.94 Da), but reasonable 
trawler6 uses an algorithm that is similar to MaxEnt 1 for 
deconv gher 
rotein 
 
 
mass
(mass difference < .01%).  Pro
olution, but requires less time for processing and adjusts for the slightly hi
mass estimates.  For this reason, the values obtained from this algorithm are typically 
lower, and after processing with Protrawler6, the neutral mass determined for the p
in Figure 2 was 14303.20 Da. 
 
Figure 4.  After processing with MaxEnt 1, the multiply charged spectrum in Figure 2 is 
deconvoluted to a zero charge (neutral) mass spectrum. 
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To apply Protrawler6 to LC/MS data, one must first build a model that accounts 
for the resolution of the mass spectrometer, whether the deconvolution will be used for 
peptides or proteins, and the typical background noise of the instrument.  For this
an analysis on peptides (which would require deisotoping and charge state 
deconvolution) using an ion trap instrument (lower resolving power) would require a 
different model than an analysis of intact proteins (requiring only charge state 
deconvolution) using a TOF instrument (higher resolving power).  The model is then 
used to create a mock protein spectrum of known mass.  This mock spectrum is used to 
fit the raw data collected from the ins
 reason, 
trument, and is adjusted iteratively until the fit 
reaches convergence.  Since the mass of the mock spectrum is known (because it was 
created by the software) once the mock spectrum satisfactorily fits the raw data, the mass 
of the protein will be determined.   
When an instrument of the same or highly similar resolution and background 
noise is used and the model is applied to the same type of analysis, i.e., intact proteins 
rather than peptides, the same model can be successfully applied to any type of protein 
analysis on that instrument.  The model is not dependant on the source of the proteins 
(e.g. standards, Shigella lysates, Clostridium lysates).  For this project, one model was 
built and applied to all of the analyses thereafter.  Since the proteins to be analyzed will 
vary in size, models that are built for a large protein are more successful because they 
more readily encompass small proteins than a small protein model can large proteins.  
The model used here was applicable from 5 – 75 kDa.  This mass range covered proteins 
utine manual inspection of the data, typically observed with this method and if af r rote
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proteins outside this range were observed, th model could be adjusted accordingly, but 
that was not necessary here. 
To verify the validity of the model, one can apply it to protein standards of known 
mass or calculate the mass manually or use MaxEnt1 as described above.  An ideal model 
produces accurate charge state deconvolution and neutral mass determination, low noise 
and few artifact peaks.  Although parameters during model development were adjusted to 
accurately account for the background noise and to minimize artifacts, the production of 
some artifacts was unavoidable.  All data compiled from Protrawler6 that was < 1% 
relative intensity compared to the base peak was removed.  This helps prevent artifacts 
from subtracting out real peaks during spectral subtraction.   
Once a model has been developed and its utility verified, it can then be applied.  
Since the length of the chromatogram and width of the typical chromatographic peak may 
change depending on which chromatographic method was used, the width of the time 
slice and the trawl start and stop times are entered individually for each chromatogram.  
The typical width used was 30 seconds.  Because the first few minutes of the 
chromatogram were from the solvent peak or system dead volume, and the last ~10 
minutes were for column cleaning and re-equilibration, no proteins eluted during this 
time.  Therefore, to minimize processing times, Protrawler6 was typically set to process 
from 2.5 – 62.5 minutes. 
 It is important to note the distinction between summing the MaxEnt data 
iteratively as opposed to summing the entire chromatogram and doing a single MaxEnt 
analysis.  By summing time slices of MaxEnt data, the noise level is reduced because 
e 
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only formerly multiply charged ions are present in the MaxEnt results.  This is in contras
to summing the entire chroma
t 
togram which would be a summation of multiply and singly 
charge
 
 data.  The mass 
spectro
t 
ng 
er simplified by using the spectral mirroring and 
spectra on of 
d data and given that the majority of background noise in LC/MS is singly 
charged, this summation would drown out nearly all low abundance multiply charged 
ions.  The retention time information is tabulated in order to distinguish two proteins of 
the same mass that have different retention times and if a protein is found to be 
interesting, its retention time could then be utilized to isolate the protein for further study 
by collecting fractions as they elute off of the column. 
In addition to lessening the complexity of the data, the application of Protrawler6
also results in a significant reduction of the overall amount of
meter is set to acquire spectra at a rate of 2 spectra/second and the 
chromatographic run time is 75.5 min (4,530 seconds) so each data file contains 9,060 
summed spectra.  But, after processing with Protrawler6, the data is reduced to one tex
file which is then converted into a single mass spectrum representing all of the proteins 
observed in the isolate.    
3.5.3. Processing of Deconvoluted Spectra 
Mass spectra are created from text files produced after Protrawler6 analysis usi
MS Manager software (Advanced Chemistry Development Laboratories, Ontario, CA).  
The data analysis process is then furth
l subtraction tools in MS Manager.  Spectral mirroring allows the comparis
two spectra with one of them being inverted (Figure 4).  Viewing the spectra in this 
manner simplifies the search for unique masses by placing the baseline (where 
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differences occur) at the center of view rather than overlaying them which places the 
baseline at the bottom of the screen.  The second tool, spectral subtraction, is useful for 
comparisons of two spectra that have a high degree of similarity; such as two diffe
serotypes of the same species, referred to as spectrum A and B in Figure 5.  Spectral 
subtraction involves removing the peaks common in both spectra from one of the spectra
within a user-defined mass accuracy window (± 2 Da is used here), leaving a new
spectrum containing only unique masses (spectrum A2).  This process is then reversed to 
produce a spectrum containing masses only unique to s
rent 
 
 
pectrum B2.  These two subtracted 
spectra
 
Figure 5.  Mirrored spectrum of E. coli O157:H7, accession # 06-1439 (top - A) and non-pathogenic 
 
 can then be mirrored, greatly simplifying the identification of unique masses 
(Figure 6). 
 
 
 
 
 
 
 
 
 
 
 
E. coli, accession # 06-0004 (bottom - B) showing many common peaks. 
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obvious.  A subtraction window of ± 2 Da was used.  
  
One difficulty with the MS Manager program is that mirroring and subtraction 
can only be performed with two spectra at a time.  This is a problem if one needs to 
compare groups of spectra such as comparing two of the O157:H7 spectra against the 
eight other E. coli and Shigella spp. studied.  One possible solution would be to compare 
each E. coli O157:H7 spectra to each non E. coli O157:H7 spectra and tabulate the results 
for each individual comparison; however, with 5 replicates of 10 isolates this would be 
very time-consuming.  To address this problem, theoretical spectra are made, i.e., the text 
files for all non O157:H7 isolates are combined, and then this text file is converted into a 
ome of which are actually artifacts from the MaxEnt 1 process, the hypothetical spectra 
 
Figure 6.  Subtracted spectra of E. coli seen in Figure 5.  Following subtraction, unique peaks become
much more 
single mass spectrum.  Since the hypothetical text file contains a large amount of masses, 
s
45 
are filtered by removing all peaks that are < 1% relative intensity of the most abundant 
(base) peak in the mass spectrum.  “Hypothetical” is used because analysis of a mixture 
of all non O157:H7 isolates at roughly the same concentration as the individual isolates 
was never performed.  However, since all of the masses of each individual isolate are 
included into the hypothetical spectrum’s text file, this new spectrum is valid for 
comparison purposes.  Furthermore, if a mixture as complex as the one described above 
were to be analyzed, it is likely that many of the lower abundance proteins would be 
missed and much poorer chromatographic resolution would occur, thereby yielding 
poorer quality data than that present in the hypothetical spectrum. 
 
  
CHAPTER 4  Characterization of Escherichia coli and Shigella Species
Utilizing Liquid Chromatography/Mass Spectrometry of Intact 
Proteins 
 
4.1. Introduction 
 
4.1.1. Natural Routes Exposure 
 
Foodborne illnesses are a significant cause of social and financial burdens even in 
industrialized nations.  In 1997, costs from foodborne illnesses in the United States alone 
were estimated at $35 billion and were attributed to medical expenses and lost 
 
2 Two of the top ten leading causes of food and waterborne illness outbreaks 
reported to the Centers for Disease Control and Prevention from 1972 - 2000 were Shiga 
toxin producing E. coli (STEC) and Shigella organisms.51 A particularly dangerous 
subset of STEC are the enterohaemorrhagic E. coli (EHEC), which include serotypes 
O157:H7, O26:H11 and O111:NM.52, 53 Annually, E. coli O157:H7 alone is responsible 
for 73,000 cases of infection, 2,100 hospitalizations and 61 deaths in the U.S..54 Notable 
was the recent outbreak of E. coli O157:H7 caused by the consumption of contaminated 
spinach which infected 199 persons resulting in 102 hospitalizations and 3 deaths.55   
 Moreover, Shigella organisms cause an estimated 400,000 cases of shigellosis 
each year in the U.S.  More severe is the impact in developing countries where 163 
million Shigella infections occur annually resulting in over 1 million deaths.  Of the four 
species of Shigella, S. sonnei and S. flexneri are the two most commonly implicated in 
human illness.56, 57 Children, the elderly and the immunocompromised are most 
productivity.
 46 
47 
susceptible to the severe sequelae of Shigella nd EHEC infections such as hemolytic 
uremic syndrome (HUS), the principle cause of renal failure for U.S. children.54, 56   
 Since natural outbreaks of 
n is the threat of these pathogens being used intentionally 
s could easily be obtained from the 
ools o
54, 56
58 
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59 
60
by 
to 
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4.1.2. Potential for Deliberate Use 
these organisms have had considerable public health 
impact, of even greater concer
as biowarfare agents.  Cultures of these organism
st f animals or humans and only a small inoculum (as few as 10 organisms) is 
required for infection.  Additionally, both E. coli and Shigella infections can be 
transmitted person to person allowing the impact to extend beyond those initially 
exposed.  STEC and some species of Shigella produce a toxin that is classified as a 
Category B select agent and deliberate use of these bacteria has been documented.  
Shigella organisms were used in battle by the Japanese in WWII  and by a disgruntled 
hospital employee in Texas to infect co-workers. Furthermore, E. coli cultures were 
found in possession of a Wisconsin man later arrested for possession of a toxin for use as 
a weapon.   
4.1.3. Review of Current Methods of Analysis  
In the event of an infectious disease outbreak or terrorist attack, key decisions 
hospital staff, public health officials and investigating authorities will have to be made 
guide medical treatment, prophylaxis and remediation.  These decisions are best made 
when they are data directed.  Clinical manifestations (malaise, abdominal pain, diarrhea 
etc.) of exposure do not unambiguously identify their cause.  Therefore, rapid, sensitive
and specific analytical methods are needed to gain further insight.  Rapid diagno
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infections, such as those leading to HUS, are crucial as early treatment with intravenou
volume expansion has been shown to decrease kidney damage and augment patient 
s 
thods are desirable to minimize false negatives and 
ositiv
lack the specificity to be considered confirmatory.  This was evident when public health 
often species specific primers are unavailable or impractical and for this reason the 
ere presence of a gene does not guarantee that protein is being expressed.  
athogens have been shown to contain 
genes t
outcome.61 Sensitive and specific me
p es respectively.  Three commonly used analytical methods in diagnostic 
microbiology laboratories are:  enzyme immunoassay (EIA), real-time polymerase chain 
reaction (PCR), and pulsed-field gel electrophoresis (PFGE).  
EIA methods are sensitive often eliminating the need for cultural enrichment, but 
response was misguided during an outbreak of gastroenteritis in which two independent 
laboratories found stool samples positive for Shiga toxin (Stx) by EIA, but further 
investigation revealed norovirus as the cause.62 Real-time PCR is a rapid and sensitive 
approach requiring 0.5 - 4 hours post culture to perform.  However, strain specific and 
specificity required in outbreak investigations is not typically afforded by this method.  
Secondly, the m
This is an important consideration as bacterial p
hat are not expressed.25-27 Finally, the gold standard for subtyping of bacteria 
during outbreak investigations is PFGE.  While this technique is capable of providing 
strain level discrimination, it is not easily automated, is labor intensive and requires a 
minimum of 2 days post culture.   
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4.1.4. Specific Aims 
 Several different reviews on the techniques employed to analyze bacteria all had 
from several different yet complimentary techniques.13, 16, 28, 63 The approach described 
here is unique in that it utilizes liquid chromatography/mass spectrometry (LC/MS) of 
intact proteins, to monitor protein expression in bacterial cells.  Ke
one common conclusion – the strongest approach is polyphasic, combining information 
y differences between 
closely
roteins 
, a 
d 
 the 
 
 
 
 
 related strains may occur within the proteome to which genetic approaches are 
insensitive (e.g., posttranslational modifications, PTMs).  One of the dominant PTMs in 
bacteria, removal of the N-terminal methionine, is estimated to occur in 50% of bacterial 
proteins.33 In total, the differences that can be observed during the comparison of p
can be qualitative:  the presence/absence of proteins, protein sequence mutations and 
PTMs, or quantitative, i.e., varying levels of protein expression.34   
To examine the efficacy of this approach as a tool in diagnostic microbiology
brief comparison with MALDI/TOF-MS was performed, then a model set of ten of 
Shigella and E. coli clinical isolates were studied (Table 6).   From these ten isolates, 
biomarkers based on protein mass, retention time and relative intensity were discovere
and evaluated for their reproducibility by performing five replicate analyses.  Finally,
validity of these markers was challenged by applying them to a blind test of clinical 
isolates. 
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Table 6.  The ten known isolates examined in this study.  ND = not determined, NM = non-motile and 
NA = not applicable. 
 
Family Enterobacteriaceae 
Genus Escherichia Shigella 
Species E. coli S. flexneri S. sonnei 
Serotype Stx (-) O111:NM O26:H11 O157:H7 ND NA 
ND 
06-0004 06-1440 06-1418 06-1439 04-0497 06-1362 
Accession 
06-0006   06-1464 06-0967 06-1364Number  
 
 
 
ed for HPLC analysis 
was pu
d 
ed 
y Services.  Cells were grown for 24 hours at a temperature of 37oC.  
rypticase soy agar plates containing 5% sheep’s blood in the presence of oxygen with 
% CO2 were used as the growth medium.  After this growth period, cells were removed 
om the plate and placed in a test tube containing 1 mL of water until the optical density 
4.2. Experimental 
4.2.1. Materials 
HPLC grade solvents (acetonitrile, formic acid and trifluoroacetic acid) were 
purchased from Fisher Scientific (Fairlawn, NJ) and 2-propanol was purchased from 
Honeywell Burdick and Jackson (Morristown, NJ).  The water utiliz
rified in house to yield organic-free 18.3 MΩ × cm using an E-pure purification 
system (Barnstead International Dubuque, IA).  Sterile water that had been autoclave
and purified with a RiOs 5 Water Purification System (Milipore Billerica, MA) was us
during bacteria preparation.  
4.2.2. Growth and Lysis    
Bacterial isolates were obtained from the Virginia Division of Consolidated 
Laborator
T
5
fr
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reading reached 1.0 using a MicroScan Turbidity Meter (Dade Behring West Sacramento, 
CA).  A 500 μL aliquot of this suspension was washed three times with 500 μL of water 
followed by centrifugation (6000 ×  temperature for 5 minutes) to rem
resi dia.  Finally, the cells were resuspended in 150 μL of th ti
H2 itrile v/v etic fter l lysis, the sample 
again centrifuged (4100 × g f .  Fo
centrifugation, 6 superna nt was rem ed and  an a ler 
MS Analysis 
ed 
aters, Milford, MA) utilizing positive ion electrospray 
ss analysis.  Ions were monitored over a mass range of 620 - 
2450 D oyed 
um 
g at room ove 
dual me e lysis solu on (1:1 
O: aceton , 0.1% trifluoroac  acid).  A  chemica was 
or 4 minutes) at room temperature llowing 
5 μL of ta ov placed in utosamp vial for 
analysis.   
4.2.3. LC/QTOF 
Intact proteins were separated by reversed phase chromatography using an 
Acquity UPLC (Waters, Milford, MA).  Gradient elution (5-55% B in 60 min) was us
at a flow rate of 0.225 mL/min where A = H2O (1% formic acid) and B = 2-propanol (1% 
formic acid).  The column was a non porous Prosphere P-HR 2.1 x 150 mm, 4 μm 
particle size (Alltech, Columbia, MD) operated at 50oC.  The autosampler was 
maintained at 15oC prior to administering the injection volume of 20 μL.   
A Q-TOF Premier (W
ionization was used for ma
altons (Da) and resolved in single reflectron (V) mode.  The parameters empl
in the MS method were optimized for sensitivity and resolution using bovine ser
albumin.   
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4.2.4. Data Processing 
The LC/MS data was processed using two software packages:  Protrawler6 and 
MS Manager.  Protrawler6 (Bioanalyte, Portland, ME) software provided automated
deconvolution of multiply charged ions by first dividing the full-scan data from the 
chromatogram into time intervals (30 seconds) and summing the data from each interva
Sequential deconvolutions were then performed to obtain neutral masses of th
that eluted during each interval.  A text file containing the neutral masses, intensities and
retention ti
 
l.  
e proteins 
 
mes was then created summarizing the results for each chromatogram.6 
 be used for further study (e.g., fraction collection) of 
protein n.  
r spectral 
 mirrored 
along the abscissa, placing the 
 which could then be used for subtraction.  A subtraction window 
of  2 Da was utilized.   
Retention time information can
s of interest or to distinguish proteins of the same mass that differ in retentio
The masses and intensities were used to create a single spectrum representing all of the 
proteins observed in the lysate using MS Manager (Advanced Chemistry Development 
Laboratories, Ontario, CA).   
To further facilitate biomarker discovery, MS Manager was employed fo
mirroring and spectral subtraction.  Spectral mirroring allowed spectra to be
baseline at the center of view.  Spectral subtraction 
removed all common peaks between two spectra within a given mass accuracy so that 
only unique ones remained.  For group and strain level comparisons involving multiple 
spectra, the text files of all isolates not in that group or strain were combined to create a 
hypothetical spectrum
±
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4.3. Results and Discussion 
4.3.1. L
eins 
ibed 
LDI-
 
 
oviding more proteins (particularly >15 kDa), other 
advanta
 
et and 
 
 
ss accuracy over gel-based approaches).  The LC/MS approach 
also allows for distinctions of proteins of the same mass that differ in retention time.  If 
C/MS vs. MALDI-TOF/MS Comparison 
 Since nearly all of the early work concerning the MS analysis of bacterial prot
has centered on MALDI-TOF20, a brief comparison with the LC/MS technique descr
here was made.  MALDI-TOF exhibits certain advantages over LC/MS.  One, by 
producing primarily singly charged ions, data interpretation is greatly simplified relative 
to ESI-MS.  MALDI-TOF is also better suited for the analysis of complex mixtures 
therefore prior separation (e.g., chromatography) is not required.  Consequently, MA
TOF has a considerable throughput advantage ~two min (after deposition and drying) 
compared to ~two hours (data acquisition and deconvolution) over LC/MS. 
 However, as can be seen in Figure 7, after automated charge state deconvolution
with Protrawler6, spectra from LC/MS are as simple to interpret as MALDI data, and are
much richer.  In addition to pr
ges to using LC/MS exist.  These include improved mass resolution and mass 
accuracy, reproducibility, and more reliable quantitative data.  The last two advantages
stem from the uneven distribution of the sample across the spot on the MALDI targ
variance in the placement and number of laser shots acquired on the sample.   
 Having retention time information allows more to be known about the biomarker
candidates.   MALDI-TOF data is analogous to that obtained from a 1D gel, while 
LC/MS data is comparable to that acquired from a 2D gel (with obvious improvements in
ma  resolution and mass 
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the effluent from the LC is split, simultaneous fraction collection and MS analysis can be 
 for further study (e.g., sequencing).  
 
performed and the collected fractions can be used
Protein isolation for further study can not be performed by MALDI-TOF; either LC or 
tandem mass spectrometry would be required. 
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Figure 7.  Comparison of MALDI/TOF-MS and LC/MS using the same S. sonnei ly
LC/MS
sate.  More 
proteins, particularly >15 kDa were observed using LC/MS. 
 same 
 
 
Figure 7 shows a comparison of MALDI/TOF and LC/QTOF data using the
sample preparation and protein extraction procedures for a S. sonnei isolate.  Reasons for 
the differences in observed proteins may include difficulty in optimizing MS conditions
over such a wide m/z range (4,000-20,000 Da, Δ = 16,000 Da) with MALDI-TOF 
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compared to (620-2,450 Da, Δ = 1,830 Da) during ESI, and the complexity of the lysate 
which may lead to ion suppression and/or detector saturation.  Although the LC step 
causes decreased throughput, this step is likely part of the reason more proteins are 
observed.  Often, distinctions between closely related strains may involve only one or a 
w proteins and for this reason the increased information content and protein yield 
bserved by the LC/MS approach is likely advantageous and was deemed worthy of 
further investigation. 
4.3.2. Biomarker Discovery 
 The process of biomarker discovery is shown in Figure 8.  First, chromatographic 
data is collected in full-scan mode (8a).  Next, automated charge state deconvolution is 
performed to yield a single mass spectrum representing all of the proteins observed in the 
chromatogram (8b).  The spectra are then mirrored (8c) and subtracted revealing unique 
masses (8d).  As seen in Figure 8d, numerous peaks appear to be unique to each isolate 
after subtraction.  However, many of these peaks were not reproducible and may have 
been artifacts from the deconvolution process.  For this reason, a protein was deemed a 
biomarker only if its unique mass, retention time and or relative intensity was observed in
ere examined to find reproducible biomarkers whose presence or absence could be used 
to iden
fe
o
 
each of the five repeated experiments.  Spectra from the ten isolates listed in Table 6 
w
tify unknown samples.  To determine the specificity of the technique, a search for 
biomarkers was made at each taxonomic level (e.g., genus, species, strain etc.).  
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Figure 8a. 
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Figure 8b. 
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Figure 8.  During biomarker discovery, LC/MS chromatograms were obtained in full-scan, positive 
ion mode (8a).  After automated charge state deconvolution using ProTrawler6, a single spectrum 
showing all of the proteins observed in each chromatogram was generated (8b) and mirrored along 
the abscissa using MS Manager (8c - top).  As can be seen in 8c, a number of similar masses were
observed between the two serotypes.  Mass spectral subtraction using a ± 2 Da window wa
subsequently employed leaving only unique masses for each serotype (8d - bottom).  The protein at 
11,779 Da was reproducibly unique to E. M during the comparison of these two 
serotypes. 
 
s 
 coli O111:N
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4.3.3. Qualitative Markers:  Mass and Retention Time 
 
 Historically, it has been difficult to distinguish Escherichia and Shigella by 
genetic approaches due to cross-reactivity with primers and probes.64 In fact, it has been 
argued that these two actually comprise one genus due to considerable overlap between 
genomes.65 The protein expression profiles of either Shigella or Escherichia isolates were 
easily distinguished from other genera (data not shown), but distinctions between 
Shigella and Escherichia were few (Figure 9).  While, no genus specific biomarkers were 
observed, Shigella and Escherichia were distinguishable using the proteins unique to 
either Shigella species. 
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Figure 9.  Mass spectral comparison of Shigella and Escherichia showed significant overlap between 
these closely-related genera. 
60 
 PCR primers for Shigella speciation are commercially unavailable.  However, 
s a 
 
 
 two.  Either way, such a small difference would likely go 
nnoticed in a gel based approach or when using a detector with less specificity such as 
ultra-violet or fluorescence spectroscopy. 
 
with LC/MS, distinctions between Shigella species were observed.  Figure 10 depict
spectral comparison of S. flexneri and S. sonnei.  The masses in bold marked with 
asterisks were found in both isolates of that Shigella species, yet were not observed in 
any of the other eight isolates studied.  The protein at mass 7,287 unique to S. flexneri has 
the same retention time (27.9 min) and nearly the same mass as a 7,273 Da protein
present in all of the E. coli and S. sonnei isolates studied.  This mass difference of 14 Da 
could be due to a PTM (e.g., methylation), an amino acid substitution (e.g., I for V) or
some combination of the
u
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Figure 10.  The mass spectra from two specie
detect biomarkers for speciation.  Unique mass
s of Shigella were both mirrored and subtracted to 
es to each species are denoted in bold-type and with 
n “*”. 
 
As an example of serotype differentiation by this approach, the two E. coli 
O157:H7 isolates were compared against the other eight isolates.  During this comparison 
a protein at mass 18,996 eluting at 43.3 minutes was discovered unique to this serotype 
thereby demonstrating the ability of this method to distinguish EHEC serotypes which are 
otherwise indistinguishable by clinical symptoms.53 Table 7 contains the masses and 
retention times for proteins that were found unique to a group such as to both O157:H7 or 
to both S. sonnei isolates etc. 
 
   
a
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Table 7.  Group specific qualitative biomarkers.  Mass (± 2 Da) is listed first followed by retention 
time (± 0.5 min) in parentheses.  * indicates a mass tolerance of ± 3 Da.  These markers were present 
in all 5 replicates. 
 
Group E. coli O157:H7 
non O157:H7 
EHEC S. flexneri S. sonnei 
Unique 
Proteins 18,996 (43.3) 
15,478 (27.1) 
24,315 (38.5) 
   *35,250 (31.4) 
16,886 (26.8) 
  7,287 (27.9) 
11,795 (27.3) 
12,235 (45.4) 
 
The two non-O157:H7 EHEC have peaks that identify them as a group as well 
(Table 7), but when each individual isolate (06-1440 or 06-1418) was compared against 
the other 9, no unique peaks were found.  It was suspected however, that one of the 
isolates might share a genetic similarity with some of the other eight isolates that was not 
shared with the other non-O157:H7 EHEC.  For this reason, the O111:NM (non-motile) 
9 Da having a retention time of 27.0 minutes was found unique to 
O111:N  
 the 
 forensic investigations, techniques that can characterize 
bacteria at the strain level are desirable for establishing cluster or outbreak relationships 
via strain relatedness.  Highly specific characterization is needed to detect and pinpoint 
the source of an outbreak such as a particular produce manufacturer or suspected 
and O26:H11 spectra were subtracted only against each other.  During this comparison, a 
protein at 11,77
M (Figure 8).  A protein of this same mass and retention time has also been
observed in S. flexneri and E. coli O157:H7 isolates.   Accordingly, during a blind test 
these two E. coli serotypes could be distinguished first by looking for the group specific 
peaks listed in Table 7 which would classify them as a non-O157:H7 EHEC, then 
observing a protein at 11,779 Da with a retention time of 27.0 minutes would indicate
sample was E. coli O111:NM.  
In epidemiological and
63 
bioweapons facility.  To this end, strain level comparisons between E. coli O157:H7 
solates were mai de.  One O157:H7 isolate studied, accession # 06-1464, has shown a 
repro e protein  Da eluti nutes n  in the
O157:H7 isolate, accession # 06-1439,  oth gella
The differences observed between these two O157:H7 isolates indicates that the method 
described here is not only capable of
 
ducibl at 14,880 ng  mi at 26.9 ot observed  other 
 or any of the er E. coli or Shi  samples.  
 identifying bacteria, but also of discerning small 
phenotypic differences which could be indicative of the pathogen’s origin and growth 
environment.  With the exception of PFGE, which indicated ~ 98% similarity, other 
established techniques (e.g., serology) found these two isolates to be identical.  In 
addition to the value of establishing strain relatedness during outbreak investigations, the
ability to distinguish two strains (such as the ones described above) that while genetically 
similar are epidemiologically unrelated, is also significant.  Figure 11 depicts the 
comparison of the two E. coli O157:H7 spectra with PFGE results in the inset.  
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producible 
oteworthy 
considering serological and PCR analysis would not be able to distinguish the two isolates from one 
another.  The gold standard method, PFGE analysis, determined ~ 98% similarity between the two 
isolates after 48 hours (inset). 
Analogous to PFGE, in which sequencing of the chromosomal fragments is not 
performed66, this approach does not involve sequencing of the biomarkers.  The 
justification being reproducible biomarkers have been observed allowing for 
characterization at the strain level without knowing the actual identity of the proteins 
involved.  Therefore, this approach could potentially be applied to bacteria whose 
genomes have not been sequenced.  In contrast, proteomic approaches that rely upon 
database results for identification purposes would have little utility for such bacteria. 
Figure 11.  Strain-level comparison of two E. coli O157:H7 isolates revealed a re
difference at mass 14,880 that was unique to accession # 06-1464.  This distinction is n
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Finally, circumventing protein sequencing eliminates a timely digestion step resulting in 
a reduced analysis time.   
4.3.4. Distinction of Isobars Differing in Retention  
Since proteins with larger quantities of, or more easily accessible, hydrophobic 
regions will stay adsorbed to the column longer,40 retention time can therefore be used to 
distinguish two different isobaric proteins.  This is critical when a sample has two or 
more different proteins of approximately the same mass.  Such was found to be the case 
for S. flexneri 04-0497.  This strain of S. flexneri has two proteins within 2 Da of mass 
18,121 that differ in retention time by nearly 16 minutes (13% B).  One protein which 
eluted at 37.1 minutes had been observed in both E. coli O157:H7 and both S. flexneri 
isolates studied.  The other protein however, eluted at 21.3 minutes and was present only 
in S. flexneri 04-0497.  Techniques yielding only mass and intensity information (e.g., 
absent from the other nine isolates.  Tables 7 and 8 could be used to identify unknowns 
based o
 
 
 
MALDI-TOF) would likely not detect this protein or mistake it as common.  Table 8 
contains masses and retention times for proteins found unique to an individual isolate and 
n the presence or absence of these proteins.  
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Table 8.  Strain level qualitative biomarkers.  Mass (± 2 Da) is listed first followed by retention time
determined. 
 
 
(± 0.5 min) in parentheses.  These markers were also present in all 5 replicates.  ND = not 
Serotype O157:H7 ND 
li 
ND 
S. flexneri 
ND 
S. flexneri 
ND 
Species/ E. coli E. coli E. co
Accession 
Number 06-1464 06-0004 06-0006 04-0497 06-0967 
Unique 8.9) 
Proteins 14,880 (26.9) 
11,694 (28.5) 
15,931 (30.2) 
  9,066 (16.3) 
11,707 (28.0) 
10,119   (27.7) 
18,860   (41.9) 
18,121   (21.1) 
10,089 (2
18,151 (21.5) 
18,874 (40.7) 
 
4.3.5. Quantitative Markers 
In addition to qualitative aspects (e.g., mass and retention time) that signify 
biomarkers, proteins that differ in intensity are also informative and may be caused by up 
or down regulation or possibly genetic engineering (to produce more toxin etc.).  The 
utility of quantitative biomarkers was evident during the analysis of the two non-
O157:H7 EHECs.  In the other eight samples, the intensity of a protein at 15,406 Da is 
much greater than one at 15,423 Da, but the trend was reversed for the two non-O157:H7
EHECs.  Interestingly, this difference involved two o
 
f the most abundant proteins in the 
sate.  For this reason, the quantitative difference was immediately obvious and no 
pectral subtraction of common peaks was required.   
Strain level quantitative differences were also observed.  In S. flexneri 04-0497, a 
rotein at mass 9,737 eluting at 26.4 minutes and highly abundant in all 9 other isolates, 
as barely detected.  Additionally, in E. coli 06-0006 a protein which elutes at 30.6 
minutes weighing 35,171 Da, common to other E. coli and S. sonnei isolates, is 
ly
s
p
w
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completely absent– most likely underexpressed below the limit of detection.  
lternativelA y, the gene for this protein could be damaged or turned off or possibly absent 
so rotein g expre aking this a qualit ction
4.3.6. Analysis of Unknowns 
challe validity iomark ussed ab ind stu
thirteen isolates distinct from the original ten was performed.  In an attempt to identify 
each unknown ec fro  th  w
dividually screened for the biomarkers listed in Table 7.  Upon inspection of the blind 
ation was shifting retention times for the markers.  During 
the earl as 
s 
obile 
 of the three biomarkers for S. 
flexneri
all 
o 
 that no p  is bein ssed at all m ative distin . 
To nge the  of the b ers disc ove, a bl dy of 
, the mass sp tra obtained m each of the irteen isolates ere 
in
study data, one initial observ
y investigation of known isolates, a retention time window of ± 0.5 minutes w
observed.  However, during the blind study, analyte retention times seemed more variable 
indicating an average window of ± 1.0 minute was more suitable.  Possible explanation
for this variation include degradation of the column or minor differences in the m
phase composition.  This variation was consistent within each run however, thus not 
affecting the relative retention times of the analytes.  When used in conjunction, the 
retention time, mass and relative intensity (RI) information allowed the biomarkers to be 
detected with confidence.   
Another observation was made concerning two
, one at 7,287 and one at 35,250 Da.  These markers have counterparts in E. coli 
and S. sonnei exhibiting the same retention times but at decreased masses of 7,273 and 
35,170 Da.  During the blind study, these two S. flexneri proteins were observed in sm
amounts (2 - 5% RI) in some of the E. coli and S. sonnei isolates.  There were tw
68 
possible reasons for this.  One, there was a small amount of S. flexneri present
isolates and they were therefore technically a mixture.  Two, the mass spectrometer 
displayed higher total ion counts during the blind study than in any of the five pr
 in these 
evious 
es.  However, even with the greater ion counts, the E. coli 
and S. 
 
ic microbiology laboratories, a complementary approach with 
certain dy 
 
rain 
replicates of the known isolat
sonnei counterparts were not observed in any of S. flexneri isolates.  Since the 
exact reason(s) was not determined, these two S. flexneri proteins were at least for the 
unknown isolates examined here, best used as quantitative biomarkers rather than
qualitative.  
Using the two S. flexneri proteins as quantitative markers, all biomarkers were 
present and absent as expected allowing all thirteen unknown isolates to be correctly 
identified.  In total, there were three S. sonnei, three S. flexneri, four E. coli O157:H7, one 
E. coli O26:H11 and two E. coli O111:NM isolates identified.  The time required to 
collect, process and examine the data to determine the identity of the unknown isolates 
was approximately two hours per sample post culture.   
4.4. Conclusions 
Using LC/MS, a technique commonly found in analytical chemistry laboratories 
but rarely found in diagnost
 advantages over typical microbiological methods has been developed.  This stu
used as a proof of concept ten isolates of Shigella and Escherichia including the species 
most often implicated in human disease to examine the efficacy of the LC/MS approach
to characterize microorganisms.  This approach has demonstrated greater specificity than 
obtainable using current real-time PCR protocols, allowing for distinctions at the st
69 
level.  Furthermore, this method is automated and is less labor intensive compared to 
PFGE, the gold standard for subtyping.  Analogous to PFGE data, LC/MS results fro
various public health laboratories could be uploaded into a public database such as 
PulseNet which is utilized to detect outbreaks around the country.67   
Using a combination of automated charge state deconvolution and spectral 
subtraction, reproducible intact protein biomarkers were observed at the species and su
species (serotype, strain, etc.) levels, and were successfully implemented for the 
identification
m 
b-
 of unknown pathogens.  These biomarkers and their corresponding protein 
express
hly 
 
r Shigella speciation for which 
ommercially unavailable.  Although no sequencing was performed 
here, th  
Ultimately, this method would be ideal as a complementary technique adding 
another dimension to the polyphasic approach of bacterial identification.  This enhanced 
polyphasic approach would then lead to more confident results which are required to 
ion profiles could be used to enhance public health response (treatment, 
remediation, etc.) by yielding insight into the identification of unknown bacteria.  Hig
specific and accurate identification of microbial pathogens in a timely manner is essential 
to guide the data directed decision making of hospital staff, public health officials and
investigating authorities.  No primers, antibodies, or proteomic database searches were 
required for this study.  This was of particular interest fo
PCR primers are c
ese protein biomarkers could be sequenced, and that information could be used to
reverse-engineer novel PCR primers.37, 68, 69 Likewise these biomarkers could be purified 
for the production of antibodies to enhance serological investigations (e.g. protein 
microarrays).70   
70 
cease production and distribution during an outbreak, or for the prosecution of suspect
terrorists.  Additionally, this LC/MS method could be expanded to monitor biomarkers 
for other foodborne pathogens and implemented to screen food items before they en
the market to prevent possible outbreaks from occurring.  
ed 
ter 
 
 CHAPTER 5  Characterization of Clostridium
Chromatography/Mass Spectrometry of Intact Proteins 
 
 Species Utilizing Liquid 
 
5.1. Introduction 
 
5.1.1. Natural Routes Exposure 
 
 Ubiquitous in the environment, Clostridium species can be found in soil, dust and 
in the intestinal flora of humans and animals.71 They are anaerobic, rod-shaped 
sporeformers72 and produce more toxins than any other genus of bacteria.73 In addition to 
their role in human disease (e.g. gastroenteritis), pathogenic Clostridia also cause illness 
in both domestic and wild animals.74 Of the approximately forty-five species that cause 
clinical conditions,75 of particular interest to this study were the species C. difficile and C. 
perfringens.  
 C. difficile is the leading cause of the nosocomial illness antibiotic associated 
diarrhea (AAD), a significant cause of morbidity and mortality particularly among 
hospitalized elderly and immunocompromised.76 C. difficile related AAD is responsible 
for increased hospital stays, resulting in an annual economic burden of $1.1 billion in the 
U.S. alone.77 Outbreaks in both long-term care facilities and hospitals have been 
reported.78 Although not typically recognized as a foodborne pathogen, C. difficile has 
been found in retail ground meat79 and commercially vacuum-packed raw meat.80 
Additionally, PCR ribotypes 017 and 027, which have been implicated in outbreaks, were 
 71 
72 
isolated from both humans and cattle raising con erns that C. difficile may be an 
emerging foodborne pathogen and indicating the possibility of zoonotic transmission.81  
 Although less common, C. perfringens is also a causative agent of AAD,76, 82 
r
perfringens was listed in the top ten by the Centers for Disease Control and Prevention 
DC) for microbial causes of foodborne outbreaks from 1972-2000.51 Additionally, 
om 1993-1997 alone, fifty-seven outbreaks of C. perfringens food poisoning were 
reported causing an estimated 250,000 cases per year, yielding costs of approximately 
500 million dollars.  Although C. perfringens has a high infectious dose (~ 10  cells), it is 
fast growing, with generation times in ground beef at 41oC, as small as 7.1 minutes being 
reported.  At this rate, a single C. perfringens cell can grow to over the infectious dose 
in just 3.5 hours.  Beyond the problems associated with ready-to-eat foods, infection 
control is challenging, as normal cooking temperatures which kill most bacteria, are 
insufficient for killing C. perfringens spores.85  
5.1.2. Potential for Deliberate Use 
 If natural outbreaks of these organisms have had such considerable public health 
impact, of even greater concern is the threat of these pathogens being used intentionally.  
The ease of access, and the toxin producing and spore forming capabilities of Clostridia 
make them viable options as bioweapons, and their cultivation for deliberate use has been 
documented.  The epsilon toxin of C. perfringens is considered by the CDC a category B 
select agent  and spores of C. perfringens were stockpiled by the Iraqi government 
c
esponsible for up to 15% of the cases.83 More known for its role in foodborne disease, C. 
(C
fr
8
84
51
73 
during the first Gulf War.86 Additionally, cultures of C. difficile were grown by th
Japanese terrorist organization Aum Shinrikyo in the mid 1990s.87  
e 
 
s 
s 
kly, which can lead to false negatives if 
 after collection or properly refrigerated.88, 89 Real-
me PC
 
.  
Furthermore, the mere presence of toxin genes does not guarantee that the genes are 
5.1.3. Review of Current Methods of Analysis 
 In the event of an infectious disease outbreak or terrorist attack, key decisions by 
hospital staff, public health officials and investigating authorities are required to guide 
medical treatment, prophylaxis and remediation.  These decisions are best made when
they are data directed.  Since individuals with C. difficile and C. perfringens infection
would exhibit similar symptoms, molecular differentiation is needed.  Two common 
molecular approaches for diagnosing Clostridia are enzyme immunoassay (EIA) and 
real-time PCR.   
 EIA methods are rapid and sensitive, and are typically used to target toxins.  
However, cross reactivity is a common problem leading to a high false positive rate 
which can misguide public health response.  Additionally, the toxins of C. perfringen
and C. difficile are unstable and can degrade quic
stool samples are not analyzed soon
ti R methods, are typically employed to amplify toxin genes.  Difficulties with this 
method can arise since many of the toxin genes in Clostridium spp. reside on 
extrachromosomal elements (e.g. plasmids or phages) and can be horizontally transferred
to other types of bacteria or even within different Clostridium species.90 The transfer of 
genetic material between C. perfringens and C. difficile has been reported91 and this 
could be problematic for methods targeting only one or few genes of a single species
74 
actually being expressed, which could result in a false positive indication of 
pathogenicity.  This is noteworthy since many bacterial pathogens possess genes that are 
 
ee 
e 
tification and characterization of bacteria have all reported a common 
 
ue 
n 
o 
e of 
e 
not expressed.25-27  
 Both EIA and real-time PCR are targeted approaches and not capable of providing
strain level typing which is desired during outbreak investigations.  Due to its high degr
of specificity, the gold standard during outbreak investigations is pulsed-field gel 
electrophoresis (PFGE).  Although highly specific, PFGE is labor intensive, not easily 
automated and time consuming - requiring a minimum of two days post culture.  Sinc
each of these molecular methods has its strengths and weaknesses, several reviews 
regarding the iden
conclusion:  the highest confidence approach is polyphasic i.e., combines information
from several complementary yet distinct techniques.13, 16, 28, 63 One molecular techniq
which can add a dimension to the polyphasic approach is mass spectrometry.92   
5.1.4. Using Mass Spectrometry to Characterize Bacteria 
 Mass spectrometry was first applied to the problem of microbial characterizatio
in the 1970s93 and subsequent books and review articles have been dedicated to the 
subject.28, 94, 20 Since that early application, mass spectrometry has been used t
characterize bacteria by detecting lipids,95 carbohydrates,96 and nucleic acids.97 The 
approach described here is distinct in that it uses reversed phase liquid 
chromatography/mass spectrometry (LC/MS) to monitor intact proteins and is capabl
providing information regarding protein mass and relative hydrophobicity (retention 
time).  Key differences between closely related bacteria may occur within the proteom
75 
to which genetic approaches are insensitive (e.g. posttranslational modificatio
making this a complementary approach.  PTMs are common in bacteria and one of the 
more dominant PTM
ns, PTMs) 
s, removal of the N-terminal methionine, results in a mass shift of -
health officials to have sound data to assist with decision making, all act as a driving 
may also be used to enhance current approaches.  The method described here is threefold:  
arkers for the 
ed 
5.2. Methods 
 
131 Dalton (Da)98 and is estimated to occur in 50% of bacterial proteins.33  
5.1.5. Specific Aims 
 The advantages of the polyphasic approach to characterizing bacteria, the 
significant socio-economic burden posed by pathogenic Clostridia, and the need of public 
force for the continuing research and development of novel molecular assays.  The aim of 
this study was to examine the efficacy of the LC/MS approach for characterizing 
pathogenic Clostridium species.  The goal was to develop a method that can provide 
complementary information compared to existing protocols and yield information that 
discovery of reproducible protein biomarkers, implementation of those biom
speciation of C. perfringens and C. difficile and characterization of each species at the 
strain level.  Finally, the validity of the species specific markers was further challeng
by applying them for the identification of unknowns in a blind study. 
5.2.1. Materials 
HPLC grade solvents (acetonitrile, formic acid and trifluoroacetic acid (TFA)) 
were purchased from Fisher Scientific (Fairlawn, NJ) and 2-propanol was purchased from
Honeywell Burdick and Jackson (Morristown, NJ).  The water utilized for HPLC analysis 
76 
was purified in-house to yield organic-free 18.3 MΩ × cm using an E-pure purification 
system (Barnstead International, Dubuque, IA).  Sterile water that had been autoclaved 
and purified with a RiOs 5 Water Purification System (Milipore, Billerica, MA) was use
during bacteria preparation.  
d 
sis    
f 
uished 
n of 
5-
 
ficle and after 24 
 two plates were combined and added to form one cell suspension.  
e grown at a temperature of 37oC.  Trypticase soy agar plates containing 
5% sheep’s blood under anaerob
5.2.2. Growth and Ly
C. perfringens clinical isolates were obtained from the Virginia Division o
Consolidated Laboratory Services and C. difficile isolates were purchased from American 
Type Culture Collection (ATCC, Manassas, VA).  Since no official nomenclature for 
describing strains exists, in-house accession numbers were used to describe the eight C. 
perfringens isolates as different strains and the five C. difficile strains were disting
by their ATCC product number.  The following strains were utilized during the portio
this study where the isolates’ identity was known:  C. perfringens (06-0385, 06-0387, 0
0025, 05-0070, 05-0076, 04-1664, 04-1672 and 04-1665); C. difficile (43593, 43594, 
43596, 43598 and 700792).  
  The C. perfringens cells were grown for 24 hours; however, the more fastidious
C. difficile required 48 hours.  To shorten the time required to reach the desired cell 
concentration, twice the number of plates were used to cultivate C. dif
hours, the cells from
Both species wer
ic conditions were used as the growth medium.  After 
this growth period, cells were removed from the plate and placed in a test tube containing 
1 mL of sterile water until the optical density reading reached 1.0 using a MicroScan 
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Turbidity Meter (Dade Behring, West Sacramento, CA).  A 500 μL aliquot of this 
suspension was washed three times with 500 μL of water followed by centrifugation 
(6000 × g at room temperature for 5 minutes) to remove residual media.   
 Two protocols for lysis were employed.  After washing the cells as described 
is protocol 1, LP1) involved adding 150 μL of 1 mg/mL 
lysozym ing at 
 of 
llet 
rnatant, the supernatant was filtered using a disposable 
analysis.   
5.2.3. LC/QTOF MS Analysis 
Intact proteins were separated by reversed phase chromatography using an 
Acquity liquid chromatograph (Waters, Milford, MA).  Gradient elution (5-55% B in 60 
min) was used at a flow rate of 0.225 mL/min where A = H2O (1% formic acid) and       
above, the first method (lys
e (HEWL) (Sigma-Aldrich, St. Louis, MO) in 20 mM NH4OAc and incubat
37oC for 30 minutes.  This was followed by four cycles of freeze/thaw in liquid nitrogen 
and a 37oC water bath respectively.  The second lysis protocol (LP2) began with 75 μL
1 mg/mL lysozyme in 20 mM NH4OAc and incubating at 37oC for 30 minutes, followed 
by four cycles of freeze/thaw.  Then, 75 μL of 1:1 H2O: acetonitrile, 5% (v/v) TFA was 
added.   
 Neither lysis protocol was capable of inactivating spores, so they were removed 
by filtration.  After centrifugation at 4100 × g for 4 minutes at room temperature to pe
the debris and clarify the supe
syringe, a blunt tip needle (BD, Franklin Lakes, NJ), and a 0.22 μm, 4 mm 
polyvinylidene fluoride (PVDF) low protein binding GV filter (Milipore).  Following 
centrifugation, 65 μL of supernatant was removed and placed in an autosampler vial for 
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B = 2-propanol (1% formic acid).  The column was a non porous Prosphere P-HR 2
150 mm, 4 μm particle size (Alltech, Columbia, MD) operated at 50oC.  The autosam
was maintained at 15oC prior to administering the injection volume of 20 μ
.1 × 
pler 
L.   
900 
 
version 4.1 (Waters).    
om the 
al.  
 containing the neutral masses, intensities and 
mmarizing the results for each chromatogram.6 
Retention tim
The LC was directly interfaced to a Q-TOF Premier (Waters) mass spectrometer 
utilizing positive ion electrospray ionization.  The capillary and cone voltages were 3
and 40 V respectively.  The desolvation gas (900 L/h) was heated to 500oC and the 
source temperature was 115oC.  Ions were monitored over a mass range of 620 - 2450 Da
and resolved in single reflectron (V) mode.  An acquisition rate of two spectra/sec was 
utilized.  Other parameters employed in the MS method were optimized for sensitivity 
and resolution using bovine serum albumin.  Data was collected using MassLynx 
software 
5.2.4. Data Processing 
LC/MS data was processed using two software packages:  Protrawler6 and MS 
Manager.  Protrawler6 (Bioanalyte, Portland, ME) software provided automated 
deconvolution of multiply charged ions by first dividing the full-scan data fr
chromatogram into time intervals (30 seconds) and summing the data from each interv
Sequential deconvolutions were then performed to obtain neutral masses of the proteins 
that eluted during each interval.  A text file
retention times was then created su
e information can be used for further study (e.g. fraction collection) of 
proteins of interest or to distinguish proteins of the same mass that differ in retention.  
The masses and intensities were used to create a single spectrum representing all of the 
79 
proteins observed in the lysate utilizing MS Manager (Advanced Chemistry Developmen
Laboratories, Ontario, CA).   
To further facilitate biomarker discovery, MS Manager was employed fo
t 
r spectral 
mirrori
at 
 
 
ram Positive Lysis Protocols 
 ic 
.  The 
e cell 
n 
son, a 
 as 
ng and spectral subtraction.  Spectral mirroring allowed spectra to be mirrored 
along the abscissa, placing the baseline at the center of view.  Spectral subtraction 
removed all common peaks between two spectra within a given mass accuracy so th
only unique ones remained.  For group and strain level comparisons involving multiple 
spectra, the text files of all isolates not in that group or strain were combined to create a
hypothetical spectrum which could then be used for subtraction.  A subtraction window
of ±  3 Da was utilized.   
5.3. Results and Discussion 
5.3.1. Development of G
Early work in this laboratory using LC/MS to discover biomarkers  for pathogen
bacteria involved Gram negative enterics (e.g. Escherichia coli and Shigella spp.)
lysis procedure used in that study was straightforward and involved reconstituting th
pellet in a solution of 50% acetonitrile with 0.1% (v/v) TFA.  This lysis procedure 
yielded complete inactivation of the cells and efficient protein extraction.  However, upo
applying the same method to the Gram positive Clostridia, the cells were neither 
inactivated nor allowed sufficient protein recovery for characterization.  For this rea
new lysis procedure was developed.  Several attempts were made using methods such
lysozyme incubation, freeze/thaw cycles and adding more acid to the Gram negative 
protocol.  Individually neither of the methods yielded protein recovery similar to that 
80 
found with the Gram negative bacteria, but when used in conjunction, two protocols 
emerged that provided sufficient protein recovery.   
The first protocol (lysis protocol 1, LP1) began with a 30 minute incubation at 
37oC after suspending the cells in 150 μL of lysozyme.  This was followed by four cyc
of freeze/thaw in liquid nitrogen and a 37oC water bath respectively.  The second 
protocol (lysis protocol 2, LP2) was the same as LP1, only 75 μL of lysozyme was used
and after the freeze thaw cycles, 75 μL of 50% acetonitrile (50% water) with 5% (v/v) 
TFA was added for a total volume of 150 μL.  Both of these protocols enabled sufficient
protein recovery, but interestingly, each method extracted a distinct set of proteins (i.e., 
by ass and retention time
les 
 
 
m ).  As depicted in Figure 12, the proteins from LP1 were 
etained longer on the column (were more hydrophobic), 
ass and exhibited less retention 
 LP1 
me 
s, 
generally larger in mass and r
while the proteins from LP2 were generally lower in m
(were more hydrophilic).   
After failed attempts to combine the lysates prior to injection, it was clear that 
most of the proteins from LP1 were not soluble in the acid/organic solution used in LP2 
as a precipitate was formed after combination.  This explains why few proteins from
were observed in LP2.  Since the proteins from LP2 were absent from LP1, LP2 must be 
further altering the cellular structure in a way that LP1 is not.  LP1 employs lysozy
incubation which hydrolyzes the β-1,4 linkages of the polysaccharide chains within the 
peptidoglycan layer and when combined with four freeze/thaw cycles, weakens the 
overall structural integrity of the cell.  LP2 utilizes essentially the same two initial step
but by adding a denaturing solvent containing 50% organic and 5% acid, further disrupts 
81 
intracellular components and/or complexes (e.g., ribosomes) and extracts only acid an
organic soluble proteins.  Three of the four marker pr
d 
oteins found for each species using 
LP2 (vide infra) matched masses in the ribosomal protein list within the Rapid 
Microorganism Identification Database (http://www.RMIDb.org/), while none of the 
species marker masses from LP1 matched.  Sequencing however, would provide m
conclusive information regarding the types of proteins extracted by each protocol.  
ore 
 
e 
two lysis protocols: LP1 and LP2.  Data from C. perfringens 05-0070 is shown.  For clarity, all 
Figure 12.  Mass vs. Retention Time plot demonstrating the differences in proteins extracted by th
proteins below 10% relative intensity were not included in this figure. 
 
 
Given that the Gram negative protocol was unsuccessful for Gram positives and 
the two newly developed Gram positive protocols LP1 and LP2 had not been tested on 
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Gram negative bacteria, prior to the analysis of an unknown, a Gram stain would be 
required.  To address this issue, both of the Gram positive lysis protocols were applied to 
the Gram negative E. coli and S. sonnei.  Both protocols enabled sufficient lysis
inactivation and yielded similar protein extraction results in terms of mass and retentio
behavior as seen with the Gram positive Clostridia.  New proteins were observed that 
were not previously observed using the Gram negative lysis protocol.  While neither
 and 
n 
 
method displayed all of the biomarkers found during the Gram negative study, when the 
results from both methods were combined, all previously observed biomarkers were 
present (data not shown).   
Combined, LP1 and LP2 can be employed regardless of the type of bacteria, 
precluding the need for a Gram stain.  While not very time consuming (~ 10 min) and 
informative, during an outbreak or terrorist event, the elimination of any unnecessary 
steps would be beneficial.  In addition, these lysis methods would be beneficial for Gram 
variable bacteria or ones that are unresponsive to the Gram stain.  It also important to 
note that unlike some lysis procedures that employ detergents (e.g. SDS) or chaotropes 
(e.g. urea), the lysates from LP1 and LP2 are amenable to mass spectrometry analysis 
without further preparation.  Furthermore, these methods are simple and can be easily 
performed under a hood preventing issues with containment and aerosolization that may 
occur with mechanical techniques (e.g. French press). 
As mentioned previously, the work described herein has three elements:  
biomarker discovery, speciation and strain level characterization.  After lysis, the process 
5.3.2. Biomarker Discovery 
83 
of biomarker discovery begins with chromatographic separation of the intact proteins
Reversed phase chromatography separates proteins based on their ability to interact with 
a hydrophobic stationary phase, with the more hydrophilic proteins being less retaine
This type of chromatography was employed rather than ion exchange or size exclusion 
chromatography because the mobile phases are amenable to mass spectrometry analysi
and are easily removed during fraction collection.   
Since electrospray ionization was used in this study, multiply charged ions were 
produced.  In order to determine the neutral mass of the proteins, the mass spectra 
containing multiply charged
.  
d.  
s 
 ions were deconvoluted using Protrawler6 software.  This 
process med 
is 
 
te, the mass spectra 
irroring and spectral subtraction using MS Manager 
softwar  observe 
 is performed throughout the entire chromatogram and the information is sum
forming a single mass spectrum depicting the neutral masses of all of the observed 
proteins from the lysate.  A mass spectrum shows the mass of the proteins on the X-ax
and the intensity or abundance of the proteins on the Y-axis.  The mass spectrum contains 
the same information as a one dimensional gel, only that the abundance is indicated by
the height of the peak rather than the color intensity of the spot.  It should be noted 
however that the mass accuracy and precision using a TOF mass spectrometer is 
significantly greater than using a 1D gel, and the improved mass resolution allows 
proteins to be confidently distinguished that are 3 Da apart.99   
After a single mass spectrum was created from the cell lysa
were compared by spectral m
e.  Mirroring allows viewing two spectra along the same baseline to better
differences.  Then, proteins common to both spectra were removed by subtraction using a 
84 
user defined mass window (± 3 Da was used here).  After subtraction, only unique 
proteins remain that may qualify as biomarkers.  A protein was deemed a biomarker only 
if its combined mass (± 3 Da) and corresponding retention time (± 0.5 min) were found 
unique after three repeated experiments performed on three different days indicating it 
was reproducibly unique. 
5.3.3. Speciation 
 
 LP1 
 
ed 
 
ms 
ent and 
 
Both lysis protocols enabled the two Clostridium species to be distinguished.  As 
seen in Figure 13a and 13b, all of the markers from LP2 weigh < 14 kDa, but when
was used the markers for each species contained a unique protein weighing > 30 kDa.   
Additionally, each species specific marker from LP1 eluted after 28.6 minutes while all 
markers from LP2 eluted prior to 28.6 minutes.  Although both lysis protocols enabl
the species to be distinguished, if rapid speciation is the goal, only LP2 could be used due
to the earlier elution of its proteins.  Since patients with AAD would exhibit similar 
clinical presentation regardless which species of Clostridium was responsible, 
identification of the cause by symptoms alone is not possible.  While similar sympto
are produced, speciation is important as the risk factors for each species are differ
for this reason species specific control measures have been recommended.76   
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Figure 13.  Speciation using both lysis protocols LP1 (top) and LP2 (bottom).  Only the biomarker 
masses are labeled.  All markers extracted from LP2 eluted prior to 28.6 minutes, while all markers 
from LP1 eluted after 28.6 minutes.  While many other proteins appear unique after subtraction, 
only the labeled masses were reproducibly unique.  
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5.3.4. Sub-species Determinations 
 In addition to inter-species comparisons, intra-species comparisons were also 
performed.  One example using C. difficile 700792 is shown in Figure 14.  In this figure, 
the results from both lysis protocols were combined in order to view them 
simultaneously.  The bottom shows the remaining four C. difficile isolates with 700792 
on top.  The masses marked in bold and denoted with an asterisk were reproducibly 
unique to this strain.  The lower molecular weight protein at 8,933 Da eluted at 16.4 
minutes and was extracted using LP2, while the larger protein at 19,548 Da eluted at 40.7 
minutes was obtained using LP1.  Strain level discriminations were achieved for both 
species.  This type of analysis is beneficial especially for C. difficile since highly virulent, 
drug-resistant strains have been reported.  These strains have been deemed ‘superbugs’ 
similar to methicillin-resistant Staphylococcus aureus (MRSA), but in the UK have 
caused more illness and mortality than MRSA.100 Additionally, C. difficile superbugs are 
potentially more challenging to disinfect since unlike S. aureus, C. difficile is sporogenic.  
Identification of these strains would direct treatment towards specific antibiotics and due 
to the virulence of these strains, would likely expedite infection control measures such as 
quarantining infected individuals etc.  
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Figure 14.  The data from both lysis protocols are combined to display proteins unique to the 70079
experiments performed on three different days.  The protein weighing 8,933 Da eluted at 16.4
minutes and was obtained using LP2, while the prot hing 19,547 Da eluted at 40.7 minutes
and was obtained using LP1.   
 
5.3.5. Isolates Indistinguishable by PFGE 
 As mentioned previously, the gold standard for strain typing during outbreak 
investigations is PFGE.  For this reason
 
2 
strain of C. difficile (marked in bold with *).  These proteins were observed in all three repeated 
 
ein weig  
, comparisons were made between the strain 
typing capabilities of PFGE and LC/MS.  Two sets of the C. perfringens isolates studied 
6-0835 and 06-0387; and 04-1464, 04-1465, 04-1672 and 05-0070) were 
distinguishable by PFGE.  Figure 15 depicts the restriction patterns for all of the C. 
erfringens isolates examined in this study, obtained using SmaI as the restriction 
nzyme.  Utilizing LC/MS, the strains in both of these sets could be distinguished 
(0
in
p
e
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incorporating proteins from both lysis protocols (Table 9), indicating the high 
discriminatory power of this approach.  Since more markers were obtained using LP1,  
this method was more informative for strain typing than LP2.  Though beneficial, the 
reversed phase chromatography step rarely exhibits the specificity needed to distinguish  
strains.  However, a clear difference was observed in the chromatograms of 06-0385 and  
06-0387 (Figure 16).   
 
 
 
 
 
 
 PFGE analysis of the eight C. perfringens strains 
 enzyme used. 
 
 
 
 
 
 
 
 
Figure 15.  Restriction patterns obtained after
employed in this study.  SmaI was the restriction
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Table 9.  Proteins found unique to each strain when compared with the other strains 
II were obtained using LP2.  The masses are (± 3 Da) and the retention times listed in parenthes
are (± 0.5 min).  These proteins were observed in all three repeated experiments performed on thr
that yielded 
100% similar restriction patterns.  Proteins marked I, were obtained from LP1 and proteins marked 
es 
ee 
different days. 
06-0385 06-0387 
  9,400 (22.8)  
13,503 (25.7)II 12,334 (28.6)
II 
34,086 (42.2)I 
II
22,160 (34.9)I 
I 
32,344 (54.0)I 42,674 (43.4)
I 
51,374 (37.2)I 42,218 (42.8)
 
04-1664 04-1665 04-1672 05-0070 
 11,031 (31.9)II 9,136 (18.9)II 29,532 (30.7)
I 
18,849 (43.1)I 
52,948 (45.3)I 
51,398 (37.5)I 9,159 (31.0)I 30,706 (38.2)
I 
41,998 (45.8)I 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
igure 16.  Overlaid chromatograms of two C. perfringens strains (06-0385 and 06-0387) that were 
distinguishable by PFGE.  06-0385 had protein weighing 32,346 Da which eluted at 54.9 minutes, 
hile 06-0387 had a protein weighing 32,385 which eluted at 52.4 minutes. 
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 In addition to biomarker discovery and speciation, the LC/MS method described 
here could be used to assist forensic and epidemiological investigations into a terrorist 
event or outbreak.  Being able to distinguish isolates that were indistinguishable by 
PFGE, the info d from this method could not only serve to discriminate 
between strains rovide insights into phenotypic differences such as the 
growing conditions or traveling patterns of a ingle strain.  These findings also encourage 
modification of the current PFGE protocols used in this laboratory to include different or 
mu  enzym ormatio ty.  One
restriction enzyme that could be included is SacII, which has proven useful for the 
 blind study.  Both lysis protocols were 
used during this study and the markers from each protocol correctly identified the species 
for every unknown tested.  Although several months had elapsed in between the time that 
the known isolates were initially examined and the unknown study was performed, all 
markers were present within the accepted tolerances of mass accuracy (± 3 Da) and 
retention time (± 0.5 min) (Table 10).  It is im
presence of the biomarkers for each species informative, but also, their absence in the 
other species provided supporting evidence toward an unknown’s identity.  In total, ten 
unknowns which had not been previously analyzed by this method (six C. perfringens 
rmation obtaine
, but may also p
s
ltiple restriction es for added inf n and specifici  additional 
analysis of both C. perfringens and C. difficile.101 
5.3.6. Identification of Unknowns 
 To further challenge the biomarkers that were utilized for speciation, they were 
applied for the identification of unknowns in a
portant to note that not only was the 
and four C. difficile isolates) were correctly identified indicating that these markers were 
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both reproducible and applicable for the speciation of unknown Clostridium isolates.  The
time required to collect, process and examine the data to determine the identity of the 
unknown isolates was approximately two hours per sample post culture. 
 
parentheses are (± 0.5 min).  These proteins were observed in all three repeated experime
performed on three different days.  LP1 = lysis protocol 1, LP2 = lysis protocol 2. 
 
 
Table 10.  Species specific biomarkers.  The masses are (± 3 Da) and the retention times listed in 
nts 
  
           C. difficile             C. perfringens  
               
 
 LP1                     9,888 (43.5)                       9,092 (28.8) 
                                                     13,599 (40.0)                     13,509 (39.4) 
                                                     44,233 (43.5)                     30,298 (44.0) 
 
            LP2           7,847 (25.1)                       6,926 (13.7) 
                                 
                                                     11,082 (14.6)                       8,965 (25.3) 
9,650 (16.9)                       8,133 (26.6) 
                                                     13,959 (28.4)                     10,324 (24.0) 
 
 
5.3.7. Potential Utility for Biomarkers 
 In total, seven biomarkers were found unique to each species (Table 10).  Beyond 
their applicability in LC/MS, they could also assist other established techniques.  Real-
time PCR and EIA methods are rapid and sensitive approaches for biomarker detecti
but neither are capable of biomarker discovery.  The protein markers found in this s
could be sequenced and then that sequence information be utilized to reverse engineer 
novel real-time PCR primers.37, 68, 69 These marker proteins were consistently found 
during both the known and unknown portion of this study indicating that not only are 
their gene sequences unique to their respective species, but that these are genes that are 
on, 
tudy 
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actually expressing the proteins they encode for.  Additionally, these markers could be 
fraction collected as they elute off of the column and have antibodies made for them.  
These proteins could then aid EIA techniques by increasing the number of analytes that 
eed to be detected in order to be considered a positive result.  Since many EIA methods 
ely reduce false positives.  One manner in which EIA approaches could detect multiple 
ave sh promise as a novel appro 70, 102
ltifaceted LC/MS m
m species.  
iomarkers, 
eciation and strain level typing.  Using two newly developed MS amenable lysis 
e discovered that enabled speciation and strain 
 
R 
n
suffer from non-specific binding, having more analytes required for confirmation will 
lik
analytes in a high throughput fashion would be in the form of protein microarrays, which 
h own ach for the analysis of bacteria.  
5.4. Conclusions 
 A mu ethod combined with novel data analysis software was 
e ed ts efficacy to characterize and identify pathogenic Clostridiuxamin  for i
The capabilities of this method are three-fold:  discovering intact protein b
sp
protocols, reproducible biomarkers wer
level characterization.  Discrimination at the species and strain levels may help guide 
treatment, prophylaxis and the implementation of proper control measures during 
outbreaks or exposure events.  This method is highly specific and was used to distinguish
strains that were 100% similar by PFGE analysis.  The biomarkers discovered in this 
study were successfully implemented during the identification of unknowns in a blind 
study and could be utilized as new targets for detection by either EIA or real-time PC
approaches. 
 
 
 
 
 
Spectrometry of Intact Proteins 
6.1.  Introduction 
6.1.1.  Applications of Protein Chromatography 
The study of proteins is an integral part of biochemistry.  Efforts to understand 
protein origin, structure and function require efficient means of extraction, purif
CHAPTER 6  Ultra Performance Liquid Chromatography/Mass 
 
 
 
ication 
n – all of which employ some type of separation.  For this reason, 
s 
e 
 
idly emerging area for intact protein separations is top-down proteomic 
nalysis.  This approach has some advantages over the more popular bottom-up method 
and characterizatio
there exists a correlation between advancements in separation techniques (e.g. liquid 
chromatography) and advancements in biochemistry.103 Intact protein separations have 
utility in numerous applications.  Separation and characterization of therapeutic protein
is of increasing concern in the pharmaceutical industry as biopharmaceuticals (e.g. 
recombinant proteins and monoclonal antibodies) now account for 25% of the new 
molecular entities entering the market.104 Manufacturers of foodstuffs need to determin
the protein content of their products as well as monitor the quality of protein 
supplements.  Moreover, public health, clinical and forensic laboratories require 
capabilities to monitor food allergens (e.g. peanut, soy and milk), disease states 
(hemoglobinopathies) and various protein toxins from sources such as plants (e.g. ricin
and abrin), venom (e.g. helothermine) and bacteria (e.g. botulinum toxin).   
A rap
a
 93 
94 
where proteins are digested and analyzed.  The complexity of the peptide mixture makes 
the bottom up approaches (e.g. shotgun proteomics) often less discerning of protein 
isoform 105
isoforms may provide ins s and can be caused by 
ms, alternative splicing and posttranslational modification.106 Other 
ater sequence coverage of individual 
protein
nal 
and 
ng 
 analysis 
 
ension 
 fractions 
can the r 
 
s which are more readily observed using a top-down approach.  Protein 
ight into cell regulation and disease state
coding polymorphis
advantages of the top-down approach include gre
s, and that intact molecular weight information is obtained.105, 107 Knowing the 
intact mass allows immediate detection of modified proteins during comparative 
proteomic investigations. 
Top-down approaches typically isolate unique proteins either by two-dimensio
(2D) gel electrophoresis (GE) or with liquid chromatography/mass spectrometry 
(LC/MS).  Drawbacks to using GE compared to LC/MS include greater difficulty in 
analyzing highly acidic, basic and hydrophobic proteins, decreased mass resolution 
accuracy, poorer reproducibility, and being more labor intensive.  Advantages of usi
reversed phase LC/MS are improved quantitation, ease of automation, samples are 
enriched on column and isolated protein fractions are amenable to further MS
without sample preparation.99, 108 Reversed phase LC/MS can be considered a 2D
approach since distinctions are made according to hydrophobicity in the first dim
and mass in the second.109 Using split-flow LC/MS, unique proteins can simultaneously 
be observed and fraction collected into a well plate.  Proteins in the collected
n be infused and investigated by mass spectrometry for structural information o
digested in-well110 and then analyzed.  Despite the advantages of the top-down approach,
95 
it is less often used due to difficulties during both mass analysis and in the 
chromatographic separation of intact proteins.  Improvements in both areas of analys
are needed to enhance the widespread use of the top-down approach.105, 107   
6.1.2.  Challenges with Intact Protein Chromatography 
Relative to small molecules and peptides, the reversed phase chromatography of 
proteins has been problematic - displaying carryover, multiple peak formation (splitting) 
and broad, misshapen peaks.  These difficulties arise in part due to slow intrapore 
diffusion times, the presence of unresolved structural microheterogeneity and 
conformational isomers, an
is 
d secondary interactions with the stationary phase.10 Broad 
peaks h
g intact 
 
s 
ave resulted in poorer resolution and therefore longer gradients resulting in 
increased run times and decreased throughput.  One potential method of improvin
protein chromatography is the use of smaller particles.111 Reducing the particle diameter 
(e.g. below 2 μm) can afford enhanced resolution and shorter run times.  Improved 
resolution is predicted from the lower plate height minimum in Van Deemter plots of 
sub-2 μm particles and faster separations are a result of the elongated linear velocity
region at that minimum.8, 9, 112   
6.1.3.  Porous vs. Nonporous Particles 
Early work using sub-2 μm particles for intact protein separations involved 
nonporous particles113 because they are mechanically strong and relatively easy to 
manufacture.  Jorgenson et al. used 1.5 μm nonporous particles and achieved peak width
and run times that were comparable to perfusion chromatography114 but with increased 
96 
sensitivity.113 However, nonporous particles have decreased surface area co
porous material.  This reduction in surface area results in decreased loading capacity 
causing mass overload at lower concentrations.9 When comparing 1 μm nonp
mpared to 
orous 
icles possess approximately 100 
times m
ns as 
sed surface 
r 
 
o 
 
 pressure on carryover.  Using a pressure range from 160 
- 1600 bar, it was found that as the pressure was increased, carryover was diminished – 
an important finding for intact protein chromatography.41 Other possible advantages such 
as increased throughput, resolution and 
PLC) 
particles to 1 μm particles with 10 nm pores, porous part
ore surface area resulting in a 22-fold increase in loading capacity.115 Increased 
sample loading capacity is important for preparative applications, for quantifying 
impurities or degradation products and when trying to detect low abundance protei
more will need to be injected in order to detect them.  Additionally, the decrea
area of nonporous columns typically results in lower retentivity112, 116 which may hampe
the separation of difficult to retain highly hydrophilic analytes.   
6.1.4.  Chromatography at Ultra High Pressure 
While the above drawbacks of nonporous particles may limit certain applications,
some researchers prefer nonporous material citing relatively reduced carryover.117 T
address this issue, Eschelbach and Jorgenson employed an in-house ultra high pressure
liquid chromatography (UHPLC) system and columns with 1.5 μm particles and 
examined the effect of increased
sensitivity were not described.   
Since the advent of commercial ultra performance liquid chromatography (U
systems, much interest has been generated regarding the prospect of achieving increased 
resolution and throughput.  The use of commercially available columns and systems is 
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vital for laboratories lacking the expertise to manufacture them in-house.  Typically, 
UPLC refers to applications using porous sub-2 μm particles, at high linear velocities 
pressures of 400 – 1000 bar on commercial systems.  UHPLC is similar, but is typic
utilized at > 1000 bar with custom built systems in academic or research laboratories.9  
6.1.5.  Specific Aims  
Many small molecule applications utilizing commercial UPLC systems hav
reported118-123 and have described benefits such as increased throughput, resolution and 
sensitivity.  The aim of this manuscript was to explore whether these same successes 
could be observed with the much more problematic and difficult to chromatograph intact 
proteins.  Using ten protein standards ranging in mass from 6 - 66
and 
ally 
e been 
 kDa, and mobile 
ts were made to examine the 
perform
 a more 
luoroacetic acid) 
were pu
phases amenable to electrospray ionization, effor
ance of UPLC relative to high performance liquid chromatography (HPLC) using 
columns differing only in particle size.  The original method employing typical 
conditions was demonstrated and then parameters such as temperature, organic solvent 
and particle diameter were optimized.  The optimized method was then applied to
complex cell lysate to determine the overall efficacy of the method. 
6.2.  Experimental 
6.2.1.  Materials   
HPLC grade solvents (acetonitrile, methanol, formic acid and trif
rchased from Fisher Scientific (Fairlawn, NJ) and 2-propanol was purchased from 
Honeywell Burdick and Jackson (Morristown, NJ).  Organic mobile phases were filtered 
using 0.2 μm PTFE filters (Pall Corporation, Ann Arbor, MI).  The water utilized for 
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LC/MS analysis was purified in-house to yield organic-free 18.3 MΩ × cm using an E
pure purification system (Barnstead International, Dubuque, IA).  The sterile water used 
during bacteria preparation was autoclaved and purified with a RiOs 5 Water Purification
System (Milipore, Billerica, MA).   
-
 
ds Preparation 
.  
ine 
pared 
s prepared 
be containing 1 mL 
idity reading reached 1.0 using a MicroScan Turbidity Meter (Dade 
amento, CA).  A 500 μL aliquot of this suspension was placed in a 1.5 
mL pro
2
6.2.2.  Protein Standar
Bovine serum albumin (BSA), horse heart myoglobin, cytochrome C, 
chymotrypsinogen A and ovalbumin were purchased from MP Biomedicals (Solon, OH)
Trypsin inhibitor (soybean), insulin (bovine pancreas), ribonuclease A (RNase A, bov
pancreas), α-lactalbumin (bovine milk) and lysozyme (HEWL) were purchased from 
Sigma-Aldrich (St. Louis, MO).  Individual stock solutions of each protein were pre
at 1 mg/mL in 20 mM NH4OAc.  An equalmolar mixture of the ten proteins wa
at 1.5 μM in 50% methanol and 0.1% formic acid. 
6.2.3.  Cell Culture and Lysis 
Escherichia coli serotype O157:H7 isolates were obtained in-house.  The cells 
were grown for 24 hours on trypticase soy agar plates containing 5% sheep’s blood at 
37oC.  Cells were then removed from the plate and placed in a test tu
of water until the turb
Behring, West Sacr
tein LoBind tube (Eppendorf, Westbury, NY) and washed three times with 500 
μL of sterile water followed by centrifugation (6000 × g at room temperature for 5 
minutes) to remove residual media.  Finally, the cells were resuspended in 150 μL of the 
lysis solution (1:1 H O: acetonitrile, 0.1% (v/v) trifluoroacetic acid).  After chemical 
99 
lysis, the sample was again centrifuged (4100 × g for 4 minutes) at room temperature.  
The supernatant was filtered using a 0.22 μm, 4 mm PVDF low protein binding GV filter
(Milipore, Billerica, MA) and 65 μL of the filtered supernatant was transferred to an 
autosampler vial for analysis.  
 
trometry 
 an 
aintaining backpressures near or 
lumn temperatures were kept below 70oC.125 The gradient 
for HPL  
 
0 
 
6.2.4.  Chromatography and Mass Spec
Intact proteins were separated by reversed phase chromatography using
Acquity UPLC (Waters, Milford, MA).  The HPLC column was the narrowbore X-bridge 
C18 BEH 300 Å 2.1 × 150 mm, 3.5 μm (Waters).  The use of these porous BEH (Ethyl-
Bridged Hybrid) particles has been described.115, 124 For comparison purposes, the UPLC 
column was identical (e.g. pore size, ligand density, carbon load) except in particle size 
(1.7 μm).  To achieve maximum column life time and to ensure a robust method, 
manufacturer recommendations were followed by m
below 690 bar (10 kpsi) and co
C was linear:  5 – 55% B in 60 minutes for a slope of 0.83%B/min.  All mobile
phases contained 1% (v/v) formic acid.  The autosampler was maintained at 15oC.  For
the 1.5 μM protein standard mixture and cell lysates, injection volumes of 2 μL (3 pmol) 
and 20 μL respectively were utilized. 
The LC was directly interfaced to a Q-TOF Premier (Waters) mass spectrometer 
utilizing positive ion electrospray ionization.  The capillary and cone voltages were 390
and 40 V respectively.  The desolvation gas (900 L/h) was heated to 500oC and the 
source temperature was 115oC.  Ions were monitored over an m/z range of 620 - 2450 Da 
and resolved in single reflectron (V) mode.  An acquisition rate of two spectra/sec was
100 
utilized.  Other parameters employed in the MS method were optimized for sensitivity 
and resolution using BSA.  Data was collected using MassLynx software version 4.1 
(Waters).   
6.2.5.  LC/MS Data Analysis 
LC/MS data was processed using two software packages:  Protrawler6 
(Bioana
6  
 
6.3.1.  Original Method 
 Figure 17 depicts a chromatogram of the ten protein standards using the original 
method.  The use of protein standards is beneficial for three reasons.  First, they are 
inexpensive and easy to obtain; therefore, more convenient for method development 
purposes than expensive or difficult to procure analytes or lysates.  Second, protein 
lyte, Portland, ME) and MS Manager (Advanced Chemistry Development 
Laboratories, Ontario, Canada).  Protrawler6 provided automated deconvolution of 
multiply charged ions by first dividing the full-scan data from the chromatogram into 
time intervals (30 seconds) and summing the data from each interval.  Sequential 
deconvolution events were then performed to obtain neutral masses of the proteins that 
eluted during each interval.  A text file containing neutral masses, intensities and 
retention times was then created summarizing the results for each chromatogram.  The
masses and intensities were utilized to create a single mass spectrum representing all of 
the proteins observed in the chromatogram using MS Manager.  MS Manager was also 
used for spectral mirroring.  For ease of comparison, spectral mirroring allows spectra to
be mirrored along the abscissa.   
6.3.  Results and discussion 
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standards have been implemented by several researchers in the past making it easy to 
compare this work with previous efforts in protein chromatography.40, 126, 127 Finally, 
protein standards are useful for quality control standards and in this laboratory, are run at 
 day’s work to ensure the LC, column and MS are working 
properl o elution 
the 
 of 
 ligand 
 column 
 
eduction in flow rate accounts for the lower diffusivity 
ile, the most commonly used organic modifier for intact 
s initially used.  A long, shallow gradient (5 - 55% B over 60 
inute
e 
the beginning and end of each
y.  Examination of Figure 17 shows over 20 minutes of dead time prior t
of RNase A and 15 minutes after the elution of ovalbumin.  It should be noted that 
focus was to develop a method applicable to cell lysate analysis and during this type
analysis several proteins will elute during the aforementioned regions.   
 The original method incorporated an HPLC column with a C18 alkyl chain
and 3.5 μm diameter particles that was operated at a moderate column temperature 
(35oC).  This column is consistent with small molecule applications; however, the
utilized in this study had a larger pore diameter (300 Å) to account for the larger size of
the analytes.  In addition, the flow rate (75 μL/min) was lower than what is typically 
implemented in small molecule applications for a column having a 2.1 mm internal 
diameter.  Given that the optimal linear velocity is proportional to the diffusion 
coefficient of the analyte128, the r
of macromolecules.  Acetonitr
protein separations10, wa
m s) was utilized to maximize resolution.  However, despite the long gradient, the 
resolution was insufficient, particularly for proteins 5 - 8 (BSA - trypsin inhibitor) th
most problematic region of the chromatogram. 
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Figure 17.  Results obtained using typically employed HPLC conditions (column temperature = 35oC 
observed for the ten protein standards used in this study.  These ten standards and their masse
provided in the inset table.  The numbers assigned to each protein were kept regardless of reten
 
6.3.2.  The Effect of Temperature  
 The first parameter investigated was temperature.  The use of elevated column 
temperature, as in high temperature liquid chromatography (HTLC)129 has been 
demonstrated to improve intact protein separations.130, 131 Increasing the temperature m
modify the properties of the column surface and alter protein structure thus affecting 
analyte retention.10 Secondly, analyte sorption kinetics increase with temperature which
is important for slowly diffusing proteins.  Incre
and acetonitrile was the organic modifier used).  Poor resolution and distorted peak shape was 
s are 
tion 
order. 
ay 
 
asing diffusivity both into and out of the 
pores minimizes band broadening; consequently, column efficiency has been shown to 
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increase with temperature.132 Finally, increased temperature reduces mobile phase 
viscosity causing a concomitant decrease in back pressure.  Decreased back pressure 
allows scaling to higher flow rates resulting in reduced run times in UPLC experiments.   
 Three temperatures at constant flow rate (75 μL/min) were utilized for 
comparison (Figure 18).  An increase in sorption kinetics was indicated by the slight 
decrease in retention time for proteins such as RNase A (#1), which eluted at 28.09 
minutes at 35oC and 25.97 minutes at 65oC.  Selectivity differences were also apparent.  
As temperature increased, the retention order of two sets of proteins – α-lactalbumin (#6) 
and myoglobin (#7), and insulin (#3) and lysozyme (#4), were reversed.  While lysozyme 
clearly lost retention as temperature increased, insulin was less susceptible to this change 
and in fact showed a slight increase in retention (36.12 minutes at 35oC and 36.44 
rea of contact with the stationary phase.133 Thus, proteins such as RNase A must either 
ese temperatures allowing increased sorption kinetics 
 dom
ost 
t 
minutes at 65oC).  This property of insulin was also observed by Szabelski et al. where 
the unfolding kinetics of insulin may have increased with temperature, allowing a greater 
a
be more resistant to unfolding at th
to inate, or upon unfolding, more hydrophilic regions are exposed which shield or 
inhibit previous binding interactions.  At 65oC four peaks were observed in the m
problematic region of the chromatogram, proteins 5 – 8.  For this reason, the optimal 
temperature was chosen to be 65oC.  To maximize column lifetime and ensure a robus
method, higher temperatures (> 65oC) were not attempted. 
 
104 
%
Time
25.00 27.50 30.00 32.50 35.00 37.50 40.00 42.50 45.00 47.50 50.00 52.50 55.00
%
0
100
25.00 27.50 30.00 32.50 35.00 37.50 40.00 42.50 45.00 47.50 50.00 52.50 55.00
%
0
100
25.00 55.0027.50 30.00 32.50 35.00 37.50 40.00 42.50 45.00 47.50 50.00 52.50
0
100 35oC
1 2 5
6
9
10
7,8
65 C
50oC
1
1
2
2
3
4
4 5 8 9
10
10
6-8
6
the temperature was increased from 35°C to 65°C the resolution for proteins 5-8 improved. 
 
6.3.3.  The Role of Organic Modifier - HPLC 
 In addition to temperature, two different organic modifiers, acetonitrile (ACN) 
and isopropanol (IPA) were examined.  These two solvents exhibit different properties 
which may alter their displacement perform nce resulting in selectivity differences.  
Acetonitrile is aprotic, more polar, less viscous and has a lower eluotropic strength than 
isopropanol (Table 11).  ACN and propyl alcohols have different effects on the 
conformation of proteins which can subsequently cause distinct 
o
3
3
4
5
7
9
 
Figure 18.  Results from the HPLC temperature study using acetonitrile as the organic modifier.  As 
a
retention behaviors.134 
s shown improved solubility of hydrophobic 
proteins.10  Dillon et al., while characterizing antibodies, found using stronger solvents 
IPA is less denaturing than ACN and ha
105 
(e.g. propanol) improved resolution and recovery by reducing secondary column 
interactions.  Additionally, an increased electrospray response was also observed when 
using propanols relative to ACN.135, 136   
 
Table 11.  Different solvent properties of acetonitrile and isopropanol.  The combination of these 
properties result in selectivity differences for the analytes in this study. 
 
 The stronger eluting power of IPA is evident from Figure 19.  Using the same 
4 minutes earlier with IPA, with less peak splitting also being observed.  This could 
sumption due to a lower %B being required 
r) 
.  
e 
 
ent and 
LC 
ACN IPA 
H+ Aprotic Protic
ε 0 37 18 
Viscosity (25 oC) 0.34 1.90 
Eluotropic strength 3.1 8.3 
column, gradient, flow rate and the optimal temperature of 65oC, ovalbumin (#10) elutes 
1
result in shorter gradients and less solvent con
for elution.  The resolution was also improved for proteins 5 – 8 (BSA – trypsin inhibito
with IPA while proteins 2 (cytochrome C) and 3 (insulin) were better resolved with ACN
Often, when attempting to better resolve a pair of proteins, changes will be made to th
gradient or perhaps a different column will be used.  However, the selectivity differences
from temperature and organic solvent may be potentially more useful or conveni
in the case of using a different column, less expensive.  To further explore the 
performance of these two solvents, their comparison was continued throughout the HP
vs. UPLC comparison.  
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Figure 19.  Using the same column, column temperature, flow adient, the HPLC 
 
all ten proteins eluted in less time when IPA was used as the organic modifier. 
er 
inimized136 and recovery of hydrophobic proteins is 
rate and gr
performance for ACN (top) was compared to IPA (bottom).  Due to its stronger eluotropic strength,
 
6.3.4.  Ultra Performance Liquid Chromatography  
 In addition to the potential benefits of increased resolution, throughput and 
sensitivity which have been observed during small molecule applications, certain aspects 
of using UPLC relative to HPLC may prove particularly attractive for intact protein 
separations.  As described above, protein carryover is reduced by operating at higher 
back pressures.41 Additionally, smaller particles have less resistance to mass transfer 
which is beneficial for slowly diffusing macromolecules.132 Furthermore, short
runtimes mean less time on column for each analyte.  As time on column decreases, on-
column limited acid hydrolysis is m
107 
improved.10 Shorter runtimes also decrease the amount of time a batch of samples spends 
in the autosampler prior to analysis.  Reducing this time may prevent sample degradation 
if the autosampler is insufficiently chilled and decrease the extent of unwanted 
proteolytic digestion if proteases are present in the sample.  For the UPLC vs. HPLC 
comparison, the effect of particle size was examined first, followed by examining the 
response of the separation to using scaled gradients.  These two factors were inspected 
for both acetonitrile and isopropanol. 
 Figures 20a and 20b depict the effect of particle size at constant temperature 
(65oC) and flow rate (75 μL/min) using acetonitrile.  Although these columns were 
identical with the exception of particle size, some selectivity differences were observed 
with proteins 3 (insulin) and 4 (lysozyme).  With the smaller particle size, the elution 
es and the sharper 
e comparison using 
order was reversed for these proteins and the resolution enhanced.  Less resistance to 
mass transfer is likely demonstrated by the slightly lower retention tim
peak shape for proteins such as chymotrypsinogen A (#9).  The sam
isopropanol is shown in Figures 21a and b.  Here, the decreased resistance to mass 
transfer is evident again from lowered retention times (e.g. chymotrypsinogen A (#9)) 
and peak shape enhancement for BSA (#5).  Also a selectivity difference occurred for 
proteins 2 (cytochrome C) and 3 (insulin).  However, with IPA, the overall increase in 
resolution is more clear - particularly between proteins 5 (BSA) and 6 (α-lactalbumin); 
and 7 (myoglobin) and 8 (trypsin inhibitor).  Using extracted ion chromatograms to better 
measure peak widths, the HPLC resolution between 7 and 8 (myoglobin and trypsin 
inhibitor) was 0.74 compared to 1.18 for UPLC.   
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Figure 20a-c.  HPLC vs. UPLC comparison using acetonitrile.  Figures 20a and 20b demonstrate a 
 3.5 
six-
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UPLC - scaledc
modification in selectivity and enhancement in resolution from decreasing the particle size from
μm (Figure 20a) to 1.7 μm (Figure 20b).  All other parameters were kept constant.  Despite the 
fold increase in throughput, this increase in resolution was not maintained upon scaling of the
gradient from a 60 minute gradient at 75 μL/min to a 10 minute gradient at 450 μL/min (Figure 20c).
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peak shape of BSA (#5) was greatly improved when smaller particles were utilized.  Upon scaling of 
the gradient (Figure 21c) from a 60 minute grad nt at 75 μL/min to a 20 minute gradient at 225 
μL/min, a three-fold increase in throughput was observed with no loss in resolution. 
 
 
 As expected, the decrease in particle size yielded improved resolution.  To further 
explore the benefits of smaller particles, the flow rate was increased and the gradient was 
scaled accordingly.  Figures 20b and 20c depict a six-fold increase in flow rate and 
decrease in gradient time from 0 – 55 %B in 60 minutes at 75 μL/min to 0 – 55 %B in 10 
minutes at 450 μL/min.  Scaling the gradient during UPLC separations first involves 
increasing the flow rate, and then decreasing the time for each gradient segment (e.g. 
initial separation, column cleaning and re-equilibration) by that same factor.  For 
 
 
Figure 21a-c.  HPLC vs. UPLC comparison using isopropanol.  Figures 21a and 21b demonstrate a 
modification in selectivity and enhancement in resolution from decreasing the particle size from 3.5 
μm (Figure 21a) to 1.7 μm (Figure 21b).  All other parameters were kept constant.  Additionally the 
ie
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example, in Figure 20c, the flow rate was increased six-fold therefore, the time for each 
segment in the gradient was decreased six-fold.  Scaling in this manner holds the number 
of column volumes per gradient segment constant. 
 The scaling of the gradient stopped at 450 μL/min for ACN because it approached 
the limit of the mass spectrometer to effectively desolvate.  Other problems associated 
with using higher flow rates may include greater solvent consumption and more dilute 
fractions during fraction collection.  While the elution time for ovalbumin (#10) was 1/6 
of its original value, the resolution was not maintained during the scale up process 
(proteins 3 and 4, insulin and lysozyme respectively).  This is in contrast to IPA in which 
the resolution was maintained and even increased for proteins 2 (cytochrome C) and 3 
(insulin) (Figure 21b and 21c).  In addition, the elution time of ovalbumin (#10) was 
approximately 1/3 of its original value.  The adient could only be scaled by 1/3 because 
maximizing column life time, with maximum ssures being approximately 745 bar 
own 
se 
e 
gr
IPA is much more viscous than ACN.  Near the end of the gradient at 225 μL/min, the 
back pressure began to exceed 690 bar, the manufacturer’s recommended limit for 
 pre
(10,800 psi).     
6.3.5.  The Role of Organic Modifier - UPLC 
 A final comparison of the two solvents using the scaled UPLC gradients is sh
in Figure 22.  In terms of the elution time of ovalbumin (#10), using ACN provides 
increased throughput.  However IPA, which elutes ovalbumin four minutes later than 
with ACN exhibits a pronounced increase in resolution.  As mentioned previously, the
standards have been commonly used by other researchers, and some have found th
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separation of cytochrome C and insulin137 and BSA and myoglobin41 to be challenging.  
However, with the IPA method described here, cytochrome C (#2) and insulin (#3) are 
separated and not only are BSA (#5) and myoglobin (#7) baseline resolved but α-
, 
lactalbumin (#6) is baseline resolved in between them.  Increased resolution allows for 
reduced ion suppression, cleaner mass spectra, purer fractions to be collected and 
simplifies chromatographic comparison and peak area determination.  For these reasons
the enhanced resolution with IPA was deemed more valuable than the improvement in 
throughput observed with ACN.   
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Figure 22.  UPLC solvent comparison using the scaled gradients for each solvent but the same UPLC 
 
later, the resolution with IPA (bottom) is significantly improved relative to ACN (top). 
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column and column temperature of 65°C.  While the elution time of ovalbumin (#10) is four minutes
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6.3.6.  Original vs. Optimized Method 
 Figure 23 compares the original and optimized methods for the protein standards
The original conditions were typical, utilizing a moderate column temperature of 3
acetonitrile as the organic solvent, 3.5 μm particles and a shallow gradient of 5 – 55 %B
in 60 minutes at a flow rate of 75 μL/min.  After systematic optimization of the me
enhanced resolution was achieved and the elution time of ovalbumin (#10) was 1/4 of its 
original value.  In fact, the entire method was completed prior to the elution of the first 
compound in the original method. 
.  
5oC, 
 
thod, 
 Additionally, a significant decrease in peak width was 
observed.  The baseline peak width of chymotrypsinogen A (#9) was approximately 45 
seconds in the original method compared to 15 seconds after optimization.  In addition to 
the 2/3 reduction of the peak width, the gradient time for the original method (60 
minutes) was also reduced by 2/3 compared to the optimized method (20 minutes).  
Likewise, the time required for column cleaning and re-equilibration was equally 
abridged from fifteen minutes to five minutes for a total runtime reduction from 
approximately 75 minutes to 25 minutes.  Moreover, since IPA is a much stronger solvent 
than ACN, the gradient and therefore the runtime could be further reduced.  Any protein 
eluting at 55 %B with ACN would require a much smaller %B when using IPA. 
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ure = 
65oC, IPA as organic modifier, 1.7 μm particle size and 20 min gradient) is completed prior to the 
 organic 
modifier, 3.5 μm particle size and 60 min gradient).  The inset more clearly reveals the resolution 
was 
calculated by taking the individual peak heights from the optimized method and dividing 
them by the corresponding peak height in the original method.  However, only a small 
increase in sensitivity was observed.  One possible explanation was that as the flow rate 
increased, the desolvation efficiency of the electrospray source decreased resulting in 
lowered MS signal.  To test this, both the 60 minute and 20 minute gradients were 
2
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Figure 23.  Method optimization before and after.  The optimized method (column temperat
elution of the first compound in the original method (column temperature = 35oC, ACN as
advantage afforded by the optimized method. 
 
6.3.7.  Sensitivity Enhancement with UPLC 
 Since the peak widths were reduced when the gradient was scaled, it was likely 
that there would be a concomitant sensitivity increase.  The change in sensitivity 
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compared using the UPLC column and IPA as the organic modifier, but at the same flow 
rate of 225 μL/min for both gradients.  During this comparison, the average increase in 
sensitivity was two-fold when using the scaled gradient.  However, when the signal 
intensities from the 60 minute gradient at 225 μL/min and 75 μL/min were compared, the 
intensity was elevated with the lower flow rate.  Thus, while the scaled gradient yielded 
narrower peaks and therefore increased sensitivity, this increase in sensitivity was 
compromised by poorer desolvation at higher flow rates.  Consequently, an increase in 
overall sensitivity of (1.4X) was observed from the HPLC vs. UPLC comparison. 
6.3.8.  Application of the Optimized Method 
 To explore the benefits of the optimized method on a more complex sample, an E. 
coli O157:H7 cell lysate was analyzed.  Using the optimal temperature and organic 
enhanced chromatographic resolution which 
alyzed is difficult to discern due to the 
omple
n, 
138
solvent, a comparison was made between HPLC and UPLC to determine what impact the 
increased resolution would have on mass spectral data quality.  The results of this 
omparison are shown in Figure 24.  The c
was obvious when only ten proteins were an
c xity of the lysate containing > 100 proteins.  Two instances of improved 
resolution with UPLC are denoted by asterisks in Figure 24a.  Despite careful 
optimization of the method, significant co-elution was evident.  The representative mass 
spectra for each technique were very similar (Figure 24b) and even upon close inspectio
no significant differences were detected.    Both spectra exhibited a biomarker unique to 
the O157:H7 serotype of E. coli weighing 18,996 Da , which eluted at 38.8 minutes 
with HPLC and 13.3 minutes with UPLC. 
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Figure 24.  A region of the chromatogram (Figure 24a -top) is used to compare the chromatographic 
results between the two lysate analyses.  Other proteins eluted during the times not shown.  * denotes 
instances of improved resolution with UPLC.  Figure 24b (bottom).  Mass spectral comparison of the 
lysate data.  No significant differences were observed between the two methods however, the data
collection and analysis time with UPLC was 1/3 that of HPLC. 
 
 Due to the overwhelming complexity of the cell lysate, the increase in resolution 
afforded by UPLC was not enough to allow more proteins to be observed, as both mass 
spectra contained approximately 150 proteins.  To this end, further efforts to reduce the 
complexity of the lysate could be made.  For instance, differential solubilization139 or 
sub-cellular proteomics140 extraction techniques could be applied.  This would yield 
multiple extracts based on differential protein solubility or different components of the 
cell being specifically lysed and extracted.  These multiple extracts could then be 
separately analyzed using the optimized method.  Additionally, UPLC could be 
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implemented to enhance 2D separations where in the first or second dimension an 
orthogonal separation such as capillary isoelectric focusing141, chromatofocusing142 or 
size exclusion chromatography143 was employed.  Relative to 1D separation, 2D 
separations afford much higher peak capacities, and the extension of this technology to E. 
coli lysates has been demonstrated.144 
 While more proteins were not observed using UPLC, the run time was reduced by 
2/3, at no cost in data quality.  In addition, not only was the data collection time reduced, 
but the data analysis time was also reduced using the UPLC method.  For the 75 minute 
HPLC chromatogram, the time required to perform automated charge state deconvolution 
with Protrawler6 was approximately 30 minutes.  This is in contrast to the 25 minute 
UPLC chromatogram which required only 10 minutes per chromatogram.  The step of 
educing the deconvolution time minimized the gap between data collection and 
terpre
ed 
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me and 
charge state deconvolution is crucial when using electrospray ionization to analyze intact 
proteins from complex cell lysate samples and streamlines the data interpretation process.  
R
in tation allowed data directed decisions to be made in less time. 
6.4.  Conclusions 
 Separation is an essential aspect of protein biochemistry and numerous 
applications for intact protein chromatography exist.  Beginning with typically employ
conditions, the parameters of temperature, organic modifier and particle size were 
optimized.  Using a combination of high temperatures, strong solvents and small particle
at very high pressure yielded optimal results, which included enhanced resolution,
sensitivity and a three-fold increase in throughput.  Increased throughput saves ti
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money in industry applications and during forensic or public health analyses allows
reporting of results to investigating authorities and hospitals.  The optimized method wa
applied to a bacterial cell lysate and a reduction in both data collection and analys
was observed with no compromise in the quality of the data.  The utilization of porous 
particles, as in UPLC, provides a usefu
 faster 
s 
is time 
l alternative to nonporous columns for researchers 
looking for greater sample loading capacities and larger retention factors. 
 
  
CHAPTER 7  Conclusions and Future Work 
 
 The overall goal of this project was the development of a novel method to detect 
and characterize microbial pathogens.  Of particular interest was developing a method 
that is complementary and at times advantageous compared to commonly employed 
assays.  When used in conjunction with existing methods, the combined approach would 
yield increased confidence prior to reporting results to investigating authorities.  Initial 
investigations involved the analysis of the Gram negative enteric pathogens Escherichia 
coli and Shigella species.  Next, the method was extended to other types of bacteria 
(Gram positive and endospore forming) during the analysis of Clostridium species.  Both 
projects discovered intact protein biomarkers for identification which were evaluated for 
their reproducibility and subsequently their utility during blind studies.  The method was 
then optimized for throughput utilizing ultra performance liquid chromatography.   
 For the E. coli and Shigella species work, a simple chemical lysis method, 
analysis by LC/MS, followed by automated charge state deconvolution and spectral 
subtraction was employed to discover biomarkers.  Reproducible intact protein markers 
that displayed unique retention times, masses and or relative intensities allowed the 
speciation of Shigella.  This is significant because real-time PCR primers for this task are 
commercially unavailable.  Serotype level distinctions were also observed.  Three 
serotypes of enterohaemorrhagic E. coli, which typically display identical symptoms, 
were investigated.  Because of the similar symptoms they produce, they can’t be 
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distinguished by symptoms alone; therefore olecular approach must be employed.  
Markers were discovered that easily distinguished E. coli O157:H7 from O126:H11 and 
O111:NM.  Once  which eluted 
at 26.2 minutes was utilized to distinguish the two non-O157:H7 serotypes from each 
other.   
 Beyond serotypic discrimination, the specificity of the method was displayed 
when two distinct isolates of E. coli O157:H7 were distinguished by a single protein.  
This level of specificity is required during epidemiological investigations of food or 
waterborne outbreaks and during forensic traceback efforts to pinpoint the source of 
exposure.  Given that thousands of people are infected with E. coli O157:H7 each year in 
the United States, assays with strain level specificity are beneficial for establishing strain 
relatedness - needed to indicate whether a series of infections were random or connected.  
The makers discovered during this investigation were then employed to correctly identify 
thirteen unknown isolates during a blind study.   
 Currently, identification of unknowns by this method is achieved through 
association with previously examined (known) pathogens, and is therefore limited to the 
types of pathogens listed in Table 2.  However, this does not limit the strain typing ability 
of the method as typically in outbreak situations where PFGE is relied upon, general 
information such as genus, species and serotype have already been determined before 
attempting to establish strain relatedness.  Future work specific to the E. coli and Shigella 
project could comprise of extending the list of pathogens investigated to other species of 
Shigella and Escherichia and additional serotypes of E. coli known to cause shigellosis. 
a m
 this distinction was made, a protein weighing 11,779 Da
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Examples include S. dysenteriae, E. vulneris145 and E. coli O91:H21.  Extension to thes
pathogens should be straightforward due to the successful proof of concept work 
described in Chapter 4.  Initial expansions of the method should be focused on areas 
where established techniques are lacking e.g., species for which no commercial real-tim
PCR pri
e 
e 
mers exist, serotypes with no commercial antibodies and strains not previously 
o 
d extracted two sets of proteins 
ores, 
ed 
 
typed by PFGE.   
 In an effort to develop a method applicable to all types of bacteria, endospore 
forming Gram positive Clostridium species were investigated.  Thirteen isolates of tw
species (five C. difficile and eight C. perfringens), for which no commercial real-time 
PCR primers exist, were used.  Both of these pathogens are known causes of antibiotic 
associated diarrhea (AAD).  Initially the lysis method utilized for Gram negative bacteria 
was implemented and found incapable of yielding sufficient protein recovery and lysis of 
Clostridia.  Therefore, two lysis methods were developed that enabled sufficient lysis and 
protein extraction.  Interestingly, each lysis metho
differing in both mass and retention time.  Due to the structural integrity of endosp
neither method was able to lyse them, thus they were removed by filtration with a 0.22 
μm PVDF filter designed to minimize protein loss during filtration.   
 After their efficacy for Gram positive bacteria was demonstrated, both lysis 
methods were then applied to the Gram negative E. coli and Shigella samples and yield
sufficient lysis and protein recovery.  Therefore, the above lysis methods are equally 
suitable for Gram positive or Gram negative bacteria thus precluding the need for a Gram
stain prior to the analysis of unknown bacteria.  While the Gram stain is not a lengthy 
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process (approximately ten minutes) and yields useful information, when rapid results are
needed, the elimination of any unnecessary step may be beneficial. 
 Not only did both lysis methods yield sufficient protein recovery, proteins from
both lysis methods enabled the speciation of Clostridium.  Their speciation allows for 
diagnosis of which species of Clostridium is the causative agent for AAD in hospital 
settings, and can d
 
 
irect future treatment and pretreatment as distinct infection control 
easur ria, 
d 
a 
ot only 
ason, these results 
f C. 
m es for each species have been recommended.  As with the Gram negative bacte
the markers found during this project were further challenged for their reproducibility an
were then successfully implemented for the speciation of ten unknown isolates during 
blind study. 
 A clear display of the specificity of the LC/MS approach described here occurred 
during the analysis of two different sets of C. perfringens isolates, which were 
indistinguishable by PFGE, the gold standard for strain differentiation.  In particular, one 
set of two isolates, accession numbers: 06-0385 and 06-0387, were distinguished n
by differences observed in the mass spectrum, but also by differences in the 
chromatogram.  These results indicated that LC/MS could yield further insight in to the 
history of an exposure than current PFGE protocols allow.  For this re
serve as basis for the recommendation that current PFGE protocols for the analysis o
perfringens be amended to include different or additional restriction enzymes which may 
give more informative restriction patterns.   
 Specific to the Clostridium project, future work could include the analysis highly 
virulent, drug resistant strains of C. difficile that have been classified as ‘superbugs’. 
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Since strain level discrimination of C. difficile was demonstrated in Chapter 5, the 
extension of the method to these strains of C. difficile would likely be successful.  
scovering biomarkers that can be used for the identification of unknowns at 
ent and 
H7 for 
 approach is complementary to existing 
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Markers that could distinguish drug resistant strains could direct the administration of 
antibiotics appropriate for treatment.  Furthermore, if distinctions are observed that 
implicate highly virulent strains, their detection could serve to expedite remediation 
processes such as disinfecting hospitals and quarantining infected patients etc. 
 Since both projects described in Chapters 4 and 5 had the same goal and other 
than the lysis and endospore filtration procedures, utilized the same methods, they have 
many common applications and implications.  The work that has been performed is two 
fold:  one, di
the species and serotype level; two, molecular subtyping of strains that may be useful for 
outbreak or source identification studies.  The first area uses LC/MS to complem
at times outperform immunoassays and real-time PCR.  These two techniques are 
targeted approaches often used for identification, but not strain level typing.  It would be 
impractical to develop primers or antibodies for every strain of E. coli O157:
example.  For this reason, a screening approach that does not require primers or 
antibodies such as PFGE is used for strain typing.  LC/MS however, can accomplish 
target detection and strain differentiation in a single analysis.  Due to the two fold nature 
of this method; its implications will be discussed separately.   
 As mentioned previously, the LC/MS
techniques by providing proteome information and is advantageous for bacteria for which
primers or antibodies are commercially unavailable.  However, in addition to being w
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established, compared to LC/MS, EIA and real-time PCR methods are less expensi
use and maintain and more amenable to multiplexing for high throughput applicatio
making them ideal for biomarker detection.  On the other hand, neither of these 
techniques have the capabilities for biomarker discovery.  The LC/MS approach her
ideal for biomarker discovery having the ability to detect hundreds of proteins in a sin
analysis and can detect subtle differences between closely related isolates.  Onc
ve to 
ns 
e is 
gle 
e 
or 
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 (7,273 Da) and the same 
discovered, the biomarkers mentioned in Chapters 4 and 5 could be purified and used f
antibody formation to enhance serological approaches or be sequenced and used to 
reverse engineer novel real-time PCR primers.  By monitoring intact proteins, 
information useful for both primer design and antibody formation are collected 
simultaneously.  In addition to antibody formation, another way to assist clinical 
immunological assays using these markers would be to have them sequenced, then grown
recombinantly and used in assays to detect host antibodies – indicating exposure.   
 Of the biomarkers discovered in this work, the best candidates for antibody 
formation or primer synthesis would be ones that are not isoforms of proteins common to 
other species or serotypes and rather, are completely unique.  For example, as de
in Chapter 4, one protein useful for the speciation of Shigella was a marker found only
S. flexneri weighing 7,287 Da which eluted at 27.9 minutes.  In all of the other E. coli and
S. sonnei isolates examined however, a protein of similar mass
retention time was observed.  Because of the similar mass and identical retention 
behavior, these proteins are likely isoforms of one another.  The mass difference of 14 Da 
could be a PTM (methylation) or an amino acid substitution (e.g. I for V) indirectly 
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caused by a SNP.  Since EIA techniques already suffer from low specificity yielding a 
high false positive rate, they would not likely be able to discern these two proteins.  
Likewise, it has been demonstrated that using the same primers, real-time PCR w
amplify two strands of DNA that differ by one base, as is the case when a SNP has 
occurred.  This will be most problematic if the SNP occurs between the primer locations.  
Once more this demonstrates the specificity of the LC/MS approach, which unlike
time PCR or immunoassays, can readily distinguish most protein isoforms.   
 An example of a protein that has no clearly observed isoforms in the isolates
studied and would therefore be a best initial candidate for primer or antibody fo
the 18,996 Da E. coli O157:H7 marker which eluted at 43.3 minutes.  Developin
primers will allow novel determinations by real-time PCR such as discriminating 
flexneri from S. sonnei or allow more confident identifications of bacteria for which only 
one or few primers exist.  Likewise, if more qualifiers for identification are added, t
ill 
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lack of specificity of EIA methods can be reduced.  For example, a serological appro
for E. coli O157:H7 may involve diagnosis for only the O and H antigens.  To help 
alleviate the high false positive rate, an antibody could be made for the 18,996 Da protein
and the EIA assay be modified so that a positive result would be reported only if all three 
antigens were detected.  
 In addition to assisting the well established techniques (e.g. real-time PCR) the 
biomarkers discovered in this study could also be used to enhance the less well kn
but promising technique of protein microarrays.146-149 Protein microarrays involve the 
immobilization labeled proteins (e.g. antibodies, enzymes) to a chip.  Samples can th
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be applied to the chip and reactions detected by fluorescence or radioactivity etc.  Recen
efforts have also reported the combination MS and microarray technology.150, 151 By 
being in array format, these devices are high throughput and can be utilized for to 
quantify and detect hundreds or thousands of specific protein-protein or other protei
ligand interactions simultaneously.  Performing an EIA experiment using a chip-based 
microarray would be an ideal platform for detecting multiple antigens for the same 
bacteria as described above for E. coli O157:H7.  Extension of this technolog
t 
n-
y to the 
ry 
 operates in full-scan mode in order to detect as many proteins 
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diagnosis of bacteria has been demonstrated.70, 102  
 As for strain typing, the second area of this work, the method described here has 
shown strain level typing capabilities which at times exceed those of PFGE.  
Additionally, LC/MS is easily automated, less labor intensive, provides complementa
information by examining the proteome instead of the genome, and for small sample 
sizes, has higher throughput.  Like PFGE data, the data from this approach could be 
uploaded to a database such as PulseNet, which monitors outbreaks by analyzing PFGE 
data from public health laboratories across the nation.   
 To better encourage other public health laboratories to consider LC/MS 
technology, efforts could be made to reduce the initial cost of the instrument.  The 
method as described here
as possible and since currently no sequencing is performed, MS/MS capabilities are not
required.  For this reason, a single TOF instrument could be used rather than a QTOF.  I
addition to being less expensive, single TOF instruments are more sensitive because th
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lack the two additional quadrupole mass analyzers and therefore would suffer less loss 
from transmission within the quadrupole region.5   
 Another issue that should be addressed before extending this approach to ot
public health laboratories is intra and inter-lab variability.  Intra-lab variability may 
include differences in the samples run at the beginning of a batch vs. those run at the en
as well as day-to-day variability.  These variations may result from lab temperature 
fluctuation which could affect mass accuracy, degradation in the cleanliness of the 
column and source which could affect retention beh
her 
d 
avior and intensity, sample 
ly stem 
y therefore to minimize 
s one as 
 
shifts, the biomarker retention times would not only be reported as ± 0.5 min, but also as 
degradation with time and minor variations in mobile phase composition which would 
also alter retention time.  Examples of inter-laboratory variability would main
from differences in LC or MS instrumentation such as discrepancies in the tubing size 
used to connect the LC and MS causing changes in dead volume or in column oven 
heating efficiencies altering retention times, or in the performance of the mass 
spectrometer used which would affect intensity and mass accuracy.  Differences in 
growing or lysis procedures may also result in variabilit
variability, partner labs should use methods and instrumentation as similar to thi
possible, i.e. an SOP should be formulated and followed as closely as possible.   
 Besides using as similar as possible methods and instrumentation across 
laboratories, another way to address intra and inter-laboratory variability would be to add
a standard protein to the lysate prior to analysis.  Being a standard, this protein’s mass 
and retention time would be well characterized before use.  To address retention time 
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on a system where on average myoglobin eluted at 32.4 minutes e.g.  If another 
laboratory uses a system with more dead volume than the one described here and 
s 
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myoglobin elutes at 32.9 minutes, 0.5 minutes could be subtracted from all of the result
in that lab prior to searching for the biomarkers observed in this laboratory.  This 
standard could also be utilized as an internal calibrant to correct for mass shifts.  Finally, 
since the same concentration would be added to all lysates, the intensities of the prot
in the lysates could be held relative to this standard and these relative intensities be 
to better ascertain quantitative differences between lysates.  This is in contrast to
absolute intensities which may vary based on source cleanliness etc.  
 Future work for strain typing analysis would involve applying the LC/MS meth
to numerous isolates from a known outbreak to see what if any new information is 
provided from this technique.  Samples from both exposed individuals and from the 
organisms collected from the actual foodstuffs responsible and other related sam
as the soil where the produce was grown etc., should be tested.  This experiment wo
use LC/MS to compare the differences and similarities amongst strains known to
common and or unrelated by both epidemiological investigation and PFGE data.  The 
isolates studied should also come with detailed case information to help answer t e 
questions:  “If a pattern is different, did it come from a different state, a different
exposure etc.?  Was the patient administered antibiotics prior to sample collection?”  
Case history would be implemented to compare and classify data sets and to examine 
how well proteomic data correlate to known case history and 
demographic/epidemiological information.   
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 Much could be learned from the analysis of superbugs.  Beyond finding m
for identification, unique proteins could be sequenced and if the protein and 
corresponding gene function is known, this could yield insight into the mechanism of 
resistance.  If the marker protein function is unknown, some understanding can be
ascertained by determining the sequence homology with known proteins in homology 
databases.  Better understanding the mechanism of a bacterium’s aptitude for developing 
resistance (drug, heat, or otherwise) could be used to predict future resistances by 
common pathogens and may assist with:  antibiotic drug design and delivery, the 
development of novel disinfectant and infection control measures or p ly
arkers 
 
ossib  learning 
 
f 
llection and analysis 
how to reverse the resistance process. 
 After successful implementation of the method for the characterization and 
identification of bacteria described in Chapters 4 and 5, the method was optimized to
improve throughput.  Chapter 6 describes the optimization of the separation of ten protein 
standards using UPLC and the application of that optimized method to cell lysate 
analysis.  Temperature, organic modifier and particle size were adjusted for optimal 
resolution, speed and sensitivity.  The optimized method incorporated a combination o
high temperature, a strong solvent and small particles at very high pressure.  This 
optimization resulted in a slight increase in sensitivity and a 2/3 reduction in runtime 
from 75 minutes to 25 minutes.  Furthermore, the reduction in the size of the data file 
resulted in a concomitant decrease in data analysis time by Prowtrawler6.  For this 
reason, the total post culture and lysis time required for data co
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decreased by 2/3 from 120 minutes (two hours) to 40 minutes.  This increase in 
throughput allows data directed decisions to be made in less time. 
 In addition to the expected sensitivity increase gained by narrowing the protein
peak width to 1/3 of its original value, utilizing UPLC yielded an unforeseen increa
sensitivity.  Protrawler6 software has a data file size limit of 2.1 GB.  If a file contains 
more than that amount of information, Protrawler6 will stop processing after 2.1 GB and 
ignore any remaining information.  During tuning of the mass spectrometer, the op
detector voltage was found to be 1900 V.  However, since the data file size is 
proportional to the number of ions counted and the time spent counting them, the 75 
minute chromatograms required a dete
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molecules (increased throughput, improved resolution etc.).  The potential applications of 
GB.  But after optimization of the method with UPLC, a 25 minute chromatogram c
be obtained using a detector voltage of 1900 V and the ensuing data file have a size of
GB or less.  Thus, incorporating UPLC not only increases the throughput three fold, it 
also allows analysis at the optimized detector voltage which will increase sensitivity and 
likely enhance the observation of lower abundance proteins.   
 Relative to small molecule analysis, intact protein chromatography is challenging
For this reason, there was some initial skepticism from within this group and even 
more than one scientist from the UPLC vendor as to whether the advantages typically 
observed with the UPLC of small molecules could also be observed with intact protein
Chapter 6 reports the first successful separation of intact proteins using commercial
UPLC equipment and demonstrates the advantages typically observed for small 
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this work are broad and include:  biopharmaceuticals, protein supplements, food
allergens, protein toxins and various top-down proteomic investiga
 
tions.  One particularly 
could be 
 
nutes in the 
hroma
 
 
tion 
interesting application that could be pursued is coupling the most recent advances in 
chromatography (e.g. UPLC) with the most recent advances in top-down proteomics 
(top-down sequencing on a chromatographic time scale).152-154 Combined, these two 
advancements could provide sequence analysis on a complex mixture of proteins in 
approximately 30 minutes post lysis – an unheard of feat.   
 In addition to the throughput enhancement using UPLC, modifications 
made to the HPLC gradient to shorten the runtime.  In the E. coli O157:H7 
chromatogram in Figure 1, it appears that much time is wasted between 45 and 58 
minutes.  However, proteins extracted using LP1 did elute during this time, with the most
well retained biomarker eluting at 54.9 minutes (Figure 16).  The tail end of this peak 
occurs at approximately 56.5 minutes and the dead volume as seen by the small non 
retained peaks at the beginning of the chromatogram in Figures 1 and 16 requires ~ 1.5 
minutes.  Therefore, the peak which finished eluting at 56.5 mi
c togram, actually left the column at 55 minutes.  Allowing an extra minute for 
retention time shifts, the gradient which currently stops at 60 minutes (Table 3) need only
run to 56 minutes.  Since the current gradient runs from 5-55%B in 60 min (0.83 
%B/min) subtracting four minutes (3.32 %B) would make the new gradient from 5-
51.68%B in 56 minutes while keeping the same slope (0.83 %B/min).  Maintaining a
constant slope allows the runtime to be reduced without affecting previous separa
results.   
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 With the last biomarker eluting at 55 minutes, the step in Table 3 of 55-95
from 60-65 minutes could be removed - saving another 5 minutes.  The new gradient 
would begin pumping 95%B at 56.01 minutes.  The remaining 10.5 minutes in Table 
would remain unchanged allowing the total runtime to be 66.5 minutes, a 9 minute 
reduction from the gradient in Table 3.  This new gradient could then be reduced by 2
using UPLC to approximately 22.2 minutes. 
 Although applied only to bacterial cell lysates in this
%B 
3 
/3 
 work, the approach 
ics analysis.  
ed 
ies 
loped.  This 
is 
e 
d for this study.  Using a combination of 
described here using UPLC/MS combined with automated charge state deconvolution 
and spectral subtraction would be well suited to aid any comparative proteom
Examples include:  the comparison of diseased cells vs. non diseased, treated diseas
cells vs. non-treated diseased cells, as well as plant and wildlife proteomic analysis e.g., 
before and after environmental stresses or exposure to pollutants etc.   
 Using LC/MS (a technique commonly found in analytical chemistry laborator
but rarely found in diagnostic microbiology laboratories), a complementary approach 
with certain advantages over typical microbiological methods has been deve
study used as a proof of concept ten isolates of Shigella and Escherichia and thirteen 
isolates of Clostridium including the species most often implicated in human disease to 
examine the efficacy of the LC/MS approach to characterize microorganisms.  Th
approach has demonstrated greater specificity than obtainable using current real-tim
PCR protocols, allowing for distinctions at the strain level, and is automated and less 
labor intensive than PFGE, the gold standard for subtyping.  No primers, antibodies or 
proteomic database searches were require
133 
a ted charge state deconvolution and spectral subtraction, reproducible intact prot
biomarkers were observed at the species and sub-species (serotype, strain) levels, and 
were successfully implemented for the identification of unknown pathogens.   
 This method could be used to enhance public health response (treatment, 
remediation, etc.) by guiding the data directed decision making of hospital staff, public 
health officials and investigating authorities.  
utoma ein 
Ultimately, this method would be ideal as a 
omple f 
od 
ure 
c mentary technique adding another dimension to the polyphasic approach o
bacterial identification.  This enhanced polyphasic approach would then lead to more 
confident results which are required to cease production and distribution during an 
outbreak, or for the prosecution of suspected terrorists.  Additionally, this LC/MS meth
could be expanded to monitor biomarkers for other foodborne pathogens or biowarfare 
agents, and implemented to screen food items before they enter the market to prevent 
possible outbreaks from occurring.  In addition to its complementary nature, the 
biomarkers discovered using this approach could be utilized to enhance current and fut
methods in the field of diagnostic microbiology.
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Appendix I  Measurement of Aflatoxin and Aflatoxin Metabolites in 
 
In addition to the previously described work on bacteria, the toxins produced from the 
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gi Aspergillus flavus, known as aflatoxins, were also investigated.  The subsequent 
erial was reproduced from the Journal of Analytical Toxicology (J. Anal. Toxicol. 
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Automated immu
chromatography/tandem
standardization was employed to detect and qu
AFG2 and the metabolites AFM1 and AFP1
nearly three orders o
range.  The method has been validated over a 12 day period by eight analysts.  This 
method is suitable for agricultural, forensic and public health laboratories during an 
accidental outbreak or a chemical terrorism event where a rapid and accurate diagnosis of
aflatoxicosis is needed. 
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Introduction 
 Due to the ever increasing threat of terrorist attacks around the globe and more 
specifically the th
that w to 
provide quality laboratory results quickly and efficiently.  In such an event, the number of 
l’s 
 
re of particular interest.  One example is aflatoxins, which were weaponized by the Iraq 
ar.  According to a United Nations Special 
ommi  produced 
D50 
ese compounds are known to be mutagenic, and teratogenic.  
linical symptoms of aflatoxin exposure include abdominal pain, rash and 
reat of a chemical terrorism ttack, analytical chemistry laboratories 
ould aid in forensic investigations and public health domains must be prepared 
 a
victims could be large and the type of warfare agent may not be immediately obvious.  
To this end, analytical methods that can provide rapid and sensitive confirmation and 
quantitation of the agent are vital in determining which agent was used, each individua
degree of exposure and the extent of the population that was exposed.1   
Of the many toxins that could be used in an attack, those previously weaponized
a
government during the first Gulf W
C ssion (UNSCOM) report, the Salman Pak weapons facility in Iraq had
2,200 liters of aflatoxins loaded in 122 mm rockets, 400 pound bombs and SCUD 
missiles.2 
Aflatoxins are secondary metabolites of the fungi Aspergillus flavus from which 
their name (A. fla.) is derived.  The predominant aflatoxins AFB1, AFB2, AFG1, and 
AFG2 are designated B and G due to their blue and green fluorescent color observed 
under UV illumination.  The most studied and most hepatotoxic aflatoxin is AFB1 (L
1.16 mg/kg in rat)3 for which the World Health Organization (WHO) suggests there is no 
safe dose.4 Moreover, th
C
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gastrointestinal bleeding.5, 6 The commonality of these symptoms with those seen in other 
lnesse  
.  
technique 
provide
il s prevent them from providing unambiguous identification of their cause, which
further emphasizes the need for an analytical method which provides more definitive 
information and enables a conclusive diagnosis.   
The work presented here builds upon previous investigations of aflatoxins in 
urine7, 8 in an effort to improve both the sensitivity and dynamic range of those methods
To improve upon the speed of previous methods, an automated immunoaffinity solid 
phase extraction method has been developed in conjunction with LC/MS/MS analysis to 
take advantage of the sensitivity, specificity, and ease of quantitation the 
s.  Figure 1 shows the structures for the four parent aflatoxins of interest and the 
metabolites of AFB1 that were chosen for this study.  
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Figure 1.  Structures of the four parent aflatoxins and the two metabolites of AFB
1
 monitored in this 
study. 
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Experimental / Apparatus / Methods 
Chemicals and Materials 
 HPLC grade methanol, acetonitrile and formic acid were purchased from Fisher 
Scientific (Fairlawn, NJ).  Deionized water was purified in house to yield organic-free 
18.3 MΩ.cm water using an E-pure purification system (Barnstead International 
Dubuque, IA).  Aflatoxin reference standards (AFB1, AFB2, AFG1, AFG2, AFM1 and 
AFP1) were purchased from Sigma-Aldrich Chemical Company (St. Louis, MO).  
Standard Preparation and Characterization 
Aflatoxins and the internal standard AFB2 were dissolved in acetonitrile and 
diluted in 85:15 MeOH:H2O (v/v) to a final concentration of 1 ng/μL.  Eight calibration 
standards, low and high quality controls (QC’s), and a urine blank containing internal 
standard were stored in 50 mL polypropylene conical tubes at 4oC.  Calibration standards 
were prepared in 1 mL of pooled human urine spiked with 25 μL of the stock solution of 
AFB2.  To all urine samples (unknowns, QC’s, blanks, and standards) an equal amount of 
85:15 MeOH:H2O was added.  For example, the highest concentration standard was made 
by mixing (per 1 mL of urine) 250 μL of the 1 ng/μL aflatoxin mixture, and 25 μL of the 
1 ng/μL internal standard for a total volume of 1.275 mL.  To the other samples the same 
andard and 85:15 MeOH:H2O while maintaining a total volume of 1.275 mL.  The final 
oncentrations of the urine standards were: 0.392, 0.784, 3.92, 7.84, 19.6, 58.8, 118, and 
96 ng/mL for the calibration standards, 1.96 and 157 ng/mL for the QC low and high 
spectively and the internal standard concentration in all samples was 19.6 ng/mL.  
amount of urine and internal standard were used but with varying amounts of aflatoxin 
st
c
1
re
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Extraction 
 Urine (1 mL) and water (1 mL) were added to glass tubes (10 x 75 mm), and 
empty tubes of the same size (for elution) were inserted into the Gilson 215 Liquid 
Handler (Middleton, WI) for automated extraction.  Custom-made immunoaffinit
columns, (3 mL barrel, 400ng aflatoxin equivalents binding capacity, Vicam, Watertow
MA) were used for the extraction.  The buffer was discarded followed by rinsing th
y 
n, 
e 
column  
5 
sted 
column twice with water, leaving a small amount of water on top of the resin.  The 
s were conditioned with water (2 x 2 mL).  After the diluted urine sample was
loaded, the column was washed with water (2 x 2 mL), followed by an air push (3 sec) 
using the Gilson solenoid valve.  The analytes were eluted from the columns with 85:1
MeOH:H2O with 1% v/v formic acid (2 x 0.5 mL), followed by an air push (30 sec). The 
extract was then transferred to an autosampler vial for LC/MS/MS analysis.  
LC/MS/MS 
 Chromatography was performed with an Agilent 1100 HPLC (Wilmington, DE) 
equipped with a 3 μm 2.0 x 150 mm phenyl-hexyl column (Phenomenex, Torrance, CA) 
at 50ºC.  1 μL injections of the extract were made on the HPLC using a mobile phase 
consisting of H2O (0.1% formic acid) (Solvent A) and acetonitrile (0.1% formic acid) 
(Solvent B).  The mobile phase gradient is given in Table 1a. 
Samples were analyzed by positive ion electrospray/tandem mass spectrometry 
operating in multiple reaction monitoring (MRM) mode on an API 4000 LC/MS/MS 
system (Applied Biosystems, Foster City, CA).  The mass spectrometer settings are li
148 
in Table 1b.  Individual compound specific parameters (i.e. declustering potentials, 
tentials, and collision cell exit potentials) were optimized for each analyte.  
Tables 1(a) and (b).  Instrument parameters for LC (a) and MS (b). 
entrance po
 
 
Time
(min) (mL/min)
0 0.325 30
Rate %B
10 0.325 30
10.1 0.325 95
11.5 0.325 95
11.51 0.325 30
15.5 0.325 30
Analyte Precursor CE Product
3
2
AFG 329 39.0 243
 
roduct ion abundances of the analyte and internal standard were used to 
ca ula  
 
actions over a period of 
two day
ak 
AFP1 299 33.0 271
AFM1 329 33.0 273
AFG2 331 35.0 31
AFB 315 37.0 287
1
AFB1 313 33.7 285
Data Analysis and Recovery 
The p
lc te analyte/internal standard ratios for quantitation.  Linear regression analysis with
“1/x” weighting was used for curve fitting.  All data processing was performed 
automatically using Analyst 1.4 software (Applied Biosystems, Foster City, CA).  
Extraction efficiencies were calculated as a percentage of the ratio of extracted analyte
peak area and the non-extracted standard peak area.  Four extr
s were performed for this study all at a concentration of 7.84 ng/mL.  Four 
injections of non-extracted standard at an equal concentration were also made.  The pe
149 
areas for the extracted and non-extracted samples were averaged and this average wa
used to calculate the ratio for each analyte. 
s 
nimal Study 
Urine samples were obtained from two male F344 rats (173-6 g body weight). 
AFB1 (91 μg/kg body weight) or the vehicle (DMSO) were administered by 
intraperitoneal injection (150 μL) on two consecutive days and rats were housed in 
metabolic cages. Urine was collected for approximately 18 hours after the second dose 
and stored at -20oC.  Urine aliquots (1 mL) were treated with 250 μL of 85:15 
MeOH:H2O and one mL of this mixture was then extracted.  The animal study was 
conducted in accordance with John Hopkins University’s Animal Care and Use 
Committee requirements which comply with the NRC’s Guide for the Care and Use of 
Laboratory Animals. 
 
1 1 s the 
se 
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Results and Discussion  
The parent aflatoxins AFB1, AFB2, AFG1 and AFG2 and also AFM1 and AFP1, 
two phase I oxidative metabolites of AFB1,9 were selected for analysis.  Both AFP1 and 
AFM  are excreted in human urine10 and studies have demonstrated that AFM  i
most abundant AFB1 metabolite found in the urine of rats and humans.11 Furthermore, 
research involving AFM1 has shown that urinary AFM1 levels reflect exposure in 
humans.12 Metabolites of AFB2, AFG1 and AFG2 were not included in this study becau
these three compounds are generally not observed in the absence of AFB1 and AFB
the most occurrent aflatoxin found in food.13  
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Urine (vs. blood or serum) was chosen as the sample matrix primarily due to its
ease of collection.  If victims are in reasonab
 
ly stable condition, they can provide a urine 
t the assistance of a medical professional.  Minimizing the workload of 
hospita y 
s 
m the 
ds are 
 
f linearity, ULOL, is determined by occupying the available 
n the column.  The use of isotopically labeled internal 
f 
he 
an 
ded to a separate aliquot of unknown and 
then re-extracted.  A second alternative would be to measure the concentration of AFB2 
sample withou
l staff is critical in a scenario such as a terrorist attack where hospitals will likel
be overwhelmed.   
AFB2 was chosen as a chemical analogue internal standard because it behave
similarly to the other aflatoxins both in the immunoaffinity column (IAC) and in the 
analytical method.  In addition, AFB2 is chromatographically well-resolved fro
other analytes and is less toxic than AFB1 and AFG1.  Chemical analogue internal 
standardization was employed for two reasons.  One, isotopically labeled standar
only available for AFB2 and are prohibitively expensive (≈ $2000 for 8.3 μg AFB2 3H). 
Two, the upper limit o
binding sites of antibody i
standards for each aflatoxin would result in more aflatoxin being added to the 
immunoaffinity column which would lower the ULOL and therefore decrease the 
dynamic range of the method.   
If AFB2 were in a real world sample, a T-test could be performed to determine i
the internal standard peak areas in unknown samples are significantly higher than t
mean AFB2 peak area in the calibration standards.  If this were the case, then since all of 
the compounds of interest are equally suitable as chemical analogue internal standards, 
aflatoxin not present in the sample would be ad
151 
by the m
e 
nity extraction of aflatoxins in various matrices has been reviewed14 
and inv
 
y, 
d 
 
 are 
 clinical 
  The 
mple corresponding to 36 samples/hour.  The efficiency 
of the a  
lts 
ethod of standard additions.  Both of these methods however would be difficult 
if the concentration of AFB2 was at or near the limit of detection so a third alternative, 
analyzing each unknown in duplicate (one with internal standard, one without), could b
employed. 
Immunoaffi
olves non-covalent binding of the toxins to monoclonal antibodies in aqueous 
environment followed by release upon denaturing of the antibodies using high organic
content solvents.  After a comparison with C18 solid phase extraction in our laborator
the immunoaffinity method was chosen due to its increased recovery, selectivity an
cleanliness of extracts.  Since the extraction columns were originally manufactured for 
food analysis, the antibody used is designed to target only the parent aflatoxins; however,
due to the structural similarities between the parent and metabolites, the metabolites
efficiently extracted as well.  For this reason, the columns can readily be used for
samples.   
Automated extraction was utilized as means to increase sample throughput.
extraction takes 1.67 minutes/sa
utomated extraction was measured at a concentration of 7.84 ng/mL in urine.  The
extraction efficiencies for each of the five compounds are shown in Table 2.  The resu
range from 80 – 93% and are in agreement with manufacturer specifications which are 
defined for food matrices. 
The best chromatographic resolution was obtained using a phenyl-hexyl column.  
Figure 2 depicts the separation of all six aflatoxins used in this study extracted from 
152 
human urine at a concentration of 19.6 ng/mL.  The MS/MS fragmentations of the 
aflatoxins are shown in Figure 3.  It can be seen that both B aflatoxins and the AFB1 
metabolites fragment by losing the carbonyl on the cylcopentanone group and that AFM1 
further breaks down by losing the two adjacent CH2 groups on the ring.  The G aflatoxins 
differ b
up 
y containing a lactone group in place of the pentanone ring structure.  These 
compounds fragment by the loss of water and the further loss of the outer carbonyl gro
and adjacent portion of the ring, as well as the loss of H2.  The fragmentation patterns 
suggest that the site of protonation for each aflatoxin is the inner carbonyl group.  These 
fragmentation patterns are based upon interpretation of the MS/MS spectra only as 
isotopically labeled experiments were not performed for reasons stated previously. 
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Figure 2. MRM extracted ion chromatogram of a 19.6 ng/mL urine extract using the transitions 
shown in Table 1b. 
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Figure 3. MS/MS fragmentation spectra for each aflatoxin with arrows indicating the precursor ion.  
(a) AFB1, (b) AFB2, (c) AFG1, (d) AFG2, (e) AFM1 and (f) AFP1.  
 
The instrument limit of detection, LOD (S/N = 3/1) for each compound is given in 
Table 3.  LOD values are reported in femtograms (fg) on column to avoid ambiguity 
inherent in using units of concentration such as parts per billion (ppb).  This ambiguity 
makes it difficult to determine a relative LOD in papers where the pertinent information 
to calculate the LOD on column is not included.15, 16 By providing the LOD as fg on 
column, the values reported in this manuscript are independent of the volume of urine 
extracted and/or injection volume and reflect the amount of sample that is detected by 
this method.  Table 3 shows the LOD for each analyte in terms of grams on column and 
in moles.  An LOD of 100 fg is equivalent to a 1 μL injection of non-extracted standard 
at 100 fg/μL.  These values meet the goal of developing a sensitive method as these 
158 
detection limits are more than 10 times lower than those previously reported17, 18 for 
aflatoxins in urine.  The limit of quantitation, LOQ (S/N = 10/1), was calculated in urine 
using the same procedure stated above.  The LOQ was determined to be 392 fg on 
column for all analytes. 
 
Table 3. Limits of detection for each analyte defined as a S/N of 3/1. 
Analyte Femtograms on 
Column
Attomoles
AFP1 50 168
AFM1 100 305
AFG2 100 302
AFG 100 305
 
A wide dynamic range is needed in the analysis of chemical warfare agents for 
two reasons.  One, since there are no studies in the literature showing the range of 
concentrations in a victim exposed to weaponized aflatoxin, having a dynamic range of 
nearly three orders of magnitude increases the likelihood that this method will cover 
relevant concentrations.  Second, the exposure of victims after an event will not be 
uniform due to their different proximities to the attack epicenter.  To achieve this goal, 
custom-made extraction columns with a lager bed size were employed.  The dynamic 
range of the method was from the LOQ at 0.392 pg – 196 pg on column for each analyte.  
1
AFB1 50 160
159 
Procedures that require time consuming concentration steps which may allow for the 
detection of lower aflatoxin levels were avoided to increase assay throughput (i.e. one 
mL of urine is extracted into one mL of MeOH:H2O with 1% v/v formic acid).  Fig
shows a calibration curve
ure 4 
 for all five toxins in human urine.  The dynamic range 
resented here meets the aforementioned goal of covering a wider range than those 
previously reported.8,17  
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regression with “1/x” weighting.  
 
Figure 4.  An eight point calibration plot from 0.392 ng/mL to 196 ng/mL in urine using line
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As seen in Figure 4, a slight deviation from linearity begins to occur at the hig
point.  This is due to the large aflatoxin/antibody ratio at this concentration.  This was 
examined by analyzing non-extracted standards which showed increased linearity at this 
same concentration and at even higher concentrations (data not presented) which 
that our ULOL is dictated by the binding capacity of the extraction column and not b
instrument.  At concentra
hest 
verified 
y the 
tions above the ULOL, the number of binding sites becomes a 
limiting factor and some unbound aflatoxin is removed during the wash step of the 
extraction.  This is an important consideration when determining the ULOL of an 
extraction method using immunoaffinity columns. 
The method was validated by analyzing a calibration curve, two quality controls 
(low and high) and a urine blank spiked with internal standard.  This experiment was 
repeated twenty times over a period of 12 days with no more than two sets being 
analyzed in a single day.  Eight analysts conducted the experiments during the 12 day 
period.  Linear regression with “1/x” weighting was used for each analyte to account for 
heteroscedasticity in the data.  The calibration standards were analyzed in a random order 
and the curves for each aflatoxin had an average correlation coefficient ≥ 0.995.  The 
quality of the method is represented by quality control low and high plots of AFG1 
(Figure 5).  Similar results were obtained for the four other toxins.  The results of the 
accuracy and precision of the method for each analyte are shown in Table 4.  The range 
highest %RSD found was 6.67%.  In all but one case the mean is ≤ one standard 
of the percent accuracy of the means for all five analytes is from 97.0 – 105.6% and the 
161 
deviatio
 
 
 
 
 
 
 
 
 
 
 
 
 
 
n away from the true value.  No significant contributions from carryover were 
seen in the blank samples. 
 
 
 
 
Figure 5a 
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Figure 5b 
 
igure 5.  Quality control plots for AFG1, (a) QC Low at 1.96 ng/mL and (b) QC High at 157 ng/mL. 
he central line represents the mean, the dashed line is 2 standard deviations and the outer line is 3 
andard deviations from the mean.  
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Table 4.  Validation results depicting the precision and accuracy of the method. 
Analyte Concentration 
(ng/mL)
Mean 
(ng/mL)
% 
Accuracy
Lower 
95% limit 
(ng/mL)
Upper 95% 
limit 
(ng/mL)
% RSD
AFB1 1.96 2.01 103 1.95 2.08 6.67
AFB1 157 153 97.5 149 157 5.18
AFM1 1.96 2.01 102 1.95 2.07 6.59
AFM1 157 152 97.0 148 156 5.58
xposed rat.  The dose administered to the rat (91 μg/kg body weight) is well below the 
D50 for rats and corresponds to a dose of several milligrams for a human adult.  A dose 
f 2-6 mg/day was observed during an outbreak of aflatoxicosis in western India,19 and 
imilar amounts were consumed in a recent outbreak in Kenya.20 It was expected that 
oughly equal amounts of the two metabolites AFM1 and AFP1 and a small amount of 
cted in the negative control rat urine sample.  AFB1, AFM1 and AFP1 were 
tively detected in urine from the AFB1 dosed rat at 1.38, 48.8 and 41.4 ng/mL.  
ting a total excretion of 5.52, 195.2 and 165.6 ng 
creatinine levels of the two urines were not measured, 
AFG1 1.96 2.07 106 2.02 2.13 5.68
AFG1 157 152 97.0 150 155 3.04
AFP1 1.96 2.03 104 1.97 2.09 6.30
AFP1 157 151 96.5 147 155 5.16
AFG2 1.96 2.06 105 2.02 2.11 4.79
AFG2 157 146 93.5 144 150 5.07
 
 
After validation, the method was further tested by analyzing the urine of an AFB1 
e
L
o
s
r
unmetabolized AFB1 may be excreted.  No aflatoxins other than the internal standard 
were dete
respec
Four mL of urine was collected indica
during the 18 hour period.  The 
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thus no comparison of the metabolite concentrations with literature values were made.  
However, relative to AFP1, the amount of AFM1 was more abundant which is consistent 
with previous studies of AFB1 exposure in rats.11, 21 Figure 6 shows the chromatograms 
for the negative control and AFB1 dosed rat urine samples.   
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Figure 6.  Chromatograms from the animal study, (a) dosed rat and (b) control rat. 
 
 
It was also expected that other metabolites of aflatoxin would be present in the 
dosed rat urine.  Precursor and product ion masses of other AFB1 metabolites18 were used 
to build a separate MRM method to detect the presence of these compounds.  Metabolites 
such as AFB-diol and AFQ1 were found.  The presence of AFQ1 was further confirmed 
by matching the retention time with a chromatogram obtained previously when AFQ1 
was commercially available (data not presented).  This method is suitable for monitoring 
Figure 6b
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other metabolites on a qualitative level, but quantitative analysis is difficult since AFM1 
and AFP1 are the only commercially available AFB1 metabolite standards. 
Conclusion 
 The LC/MS/MS method described uses less urine and has lower limits of 
detection than previously reported methods.  Other advantages of this approach are the 
specificity of both immunoaffinity extraction and tandem mass spectrometry, and no 
requirement for derivitization.  The dynamic range of 0.392 – 196 pg on column 
combined with an automated extraction yield rapid results over a wide range of exposure.  
This method is well suited to aid forensic and public health laboratories during the 
investigation of a terrorist attack by providing confirmation of military/civilian exposure 
to weaponized aflatoxin.  In addition, the method presented here can be utilized to 
diagnose aflatoxicosis22 caused by consumption of a food supply contaminated 
intentionally by the hands of terrorists or accidentally during an outbreak.19, 23, 24  
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